151
|
Adams J, Aggarwal MM, Ahammed Z, Amonett J, Anderson BD, Arkhipkin D, Averichev GS, Badyal SK, Bai Y, Balewski J, Barannikova O, Barnby LS, Baudot J, Bekele S, Belaga VV, Bellwied R, Berger J, Bezverkhny BI, Bharadwaj S, Bhasin A, Bhati AK, Bhatia VS, Bichsel H, Billmeier A, Bland LC, Blyth CO, Bonner BE, Botje M, Boucham A, Brandin AV, Bravar A, Bystersky M, Cadman RV, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Carroll J, Castillo J, Cebra D, Chajecki Z, Chaloupka P, Chattopdhyay S, Chen HF, Chen Y, Cheng J, Cherney M, Chikanian A, Christie W, Coffin JP, Cormier TM, Cramer JG, Crawford HJ, Das D, Das S, de Moura MM, Derevschikov AA, Didenko L, Dietel T, Dogra SM, Dong WJ, Dong X, Draper JE, Du F, Dubey AK, Dunin VB, Dunlop JC, Dutta Mazumdar MR, Eckardt V, Edwards WR, Efimov LG, Emelianov V, Engelage J, Eppley G, Erazmus B, Estienne M, Fachini P, Faivre J, Fatemi R, Fedorisin J, Filimonov K, Filip P, Finch E, Fine V, Fisyak Y, Foley KJ, Fomenko K, Fu J, Gagliardi CA, Gans J, Ganti MS, Gaudichet L, Geurts F, Ghazikhanian V, Ghosh P, Gonzalez JE, Grachov O, Grebenyuk O, Grosnick D, Guertin SM, Guo Y, Gupta A, Gutierrez TD, Hallman TJ, Hamed A, Hardtke D, Harris JW, Heinz M, Henry TW, Hepplemann S, Hippolyte B, Hirsch A, Hjort E, Hoffmann GW, Huang HZ, Huang SL, Hughes EW, Humanic TJ, Igo G, Ishihara A, Jacobs P, Jacobs WW, Janik M, Jiang H, Jones PG, Judd EG, Kabana S, Kang K, Kaplan M, Keane D, Khodyrev VY, Kiryluk J, Kisiel A, Kislov EM, Klay J, Klein SR, Klyachko A, Koetke DD, Kollegger T, Kopytine M, Kotchenda L, Kramer M, Kravtsov P, Kravtsov VI, Krueger K, Kuhn C, Kulikov AI, Kumar A, Kunz CL, Kutuev RK, Kuznetsov AA, Lamont MAC, Landgraf JM, Lange S, Laue F, Lauret J, Lebedev A, Lednicky R, Lehocka S, LeVine MJ, Li C, Li Q, Li Y, Lindenbaum SJ, Lisa MA, Liu F, Liu L, Liu QJ, Liu Z, Ljubicic T, Llope WJ, Long H, Longacre RS, Lopez-Noriega M, Love WA, Lu Y, Ludlam T, Lynn D, Ma GL, Ma JG, Ma YG, Magestro D, Mahajan S, Mahapatra DP, Majka R, Mangotra LK, Manweiler R, Margetis S, Markert C, Martin L, Marx JN, Matis HS, Matulenko YA, McClain CJ, McShane TS, Meissner F, Melnick Y, Meschanin A, Miller ML, Milosevich Z, Minaev NG, Mironov C, Mischke A, Mishra DK, Mitchell J, Mohanty B, Molnar L, Moore CF, Morozov DA, Munhoz MG, Nandi BK, Nayak SK, Nayak TK, Nelson JM, Netrakanti PK, Nikitin VA, Nogach LV, Nurushev SB, Odyniec G, Ogawa A, Okorokov V, Oldenburg M, Olson D, Pal SK, Panebratsev Y, Panitkin SY, Pavlinov AI, Pawlak T, Peitzmann T, Perevoztchikov V, Perkins C, Peryt W, Petrov VA, Phatak SC, Picha R, Planinic M, Pluta J, Porile N, Porter J, Poskanzer AM, Potekhin M, Potrebenikova E, Potukuchi BVKS, Prindle D, Pruneau C, Putschke J, Rai G, Rakness G, Raniwala R, Raniwala S, Ravel O, Ray RL, Razin SV, Reichhold D, Reid JG, Renault G, Retiere F, Ridiger A, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Rose A, Roy C, Ruan L, Sahoo R, Sakrejda I, Salur S, Sandweiss J, Savin I, Sazhin PS, Schambach J, Scharenberg RP, Schmitz N, Schroeder LS, Schweda K, Seger J, Seyboth P, Shahaliev E, Shao M, Shao W, Sharma M, Shen WQ, Shestermanov KE, Shimanskiy SS, Sichtermann E, Simon F, Singaraju RN, Skoro G, Smirnov N, Snellings R, Sood G, Sorensen P, Sowinski J, Speltz J, Spinka HM, Srivastava B, Stadnik A, Stanislaus TDS, Stock R, Stolpovsky A, Strikhanov M, Stringfellow B, Suaide AAP, Sugarbaker E, Suire C, Sumbera M, Surrow B, Symons TJM, Szanto de Toledo A, Szarwas P, Tai A, Takahashi J, Tang AH, Tarnowsky T, Thein D, Thomas JH, Timoshenko S, Tokarev M, Trentalange S, Tribble RE, Tsai OD, Ulery J, Ullrich T, Underwood DG, Urkinbaev A, Van Buren G, van Leeuwen M, Vander Molen AM, Varma R, Vasilevski IM, Vasiliev AN, Vernet R, Vigdor SE, Viyogi YP, Vokal S, Voloshin SA, Vznuzdaev M, Waggoner WT, Wang F, Wang G, Wang G, Wang XL, Wang Y, Wang Y, Wang ZM, Ward H, Watson JW, Webb JC, Wells R, Westfall GD, Wetzler A, Whitten C, Wieman H, Wissink SW, Witt R, Wood J, Wu J, Xu N, Xu Z, Xu ZZ, Yamamoto E, Yepes P, Yurevich VI, Zanevsky YV, Zhang H, Zhang WM, Zhang ZP, Zolnierczuk PA, Zoulkarneev R, Zoulkarneeva Y, Zubarev AN. Azimuthal anisotropy and correlations at large transverse momenta in p + p and Au + Au collisions at square root sNN=200 GeV. PHYSICAL REVIEW LETTERS 2004; 93:252301. [PMID: 15697893 DOI: 10.1103/physrevlett.93.252301] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/09/2004] [Indexed: 05/24/2023]
Abstract
Results on high transverse momentum charged particle emission with respect to the reaction plane are presented for Au + Au collisions at square root s(NN)=200 GeV. Two- and four-particle correlations results are presented as well as a comparison of azimuthal correlations in Au + Au collisions to those in p + p at the same energy. The elliptic anisotropy v(2) is found to reach its maximum at p(t) approximately 3 GeV/c, then decrease slowly and remain significant up to p(t) approximately 7-10 GeV/c. Stronger suppression is found in the back-to-back high-p(t) particle correlations for particles emitted out of plane compared to those emitted in plane. The centrality dependence of v(2) at intermediate p(t) is compared to simple models based on jet quenching.
Collapse
|
152
|
Sardana KS, Koranne RV, Mahajan S, Bhushan P. Correlation of bacterial index (BI) and bacterial index of granuloma (BIG) in leprosy--is there a therapeutic relevance? INDIAN JOURNAL OF LEPROSY 2004; 76:363-9. [PMID: 16119149] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/04/2023]
|
153
|
Dorothy A, Kamboj M, Reddy BS, Mahajan S, Boaz K. Sturge Weber syndrome. Indian J Dent Res 2004; 15:152-4. [PMID: 16035646] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/03/2023] Open
Abstract
A variant of hemangioma and an uncommon congenital condition, the Sturge Weber syndrome (SWS), also called encephalo trigeminal angiomatosis, is a neurocutaneous disorder with angiomas involving the skin of the face (cutaneous angioma) and pia arachnoid (leptomeningeal angioma). It occurs typically in the ophthalmic and maxillary distributions of the trigeminal nerve (1,2). Here we present a case of a 14 year old girl.
Collapse
|
154
|
Kashyap R, Behl RK, Mahajan S, Jaret P, Patial RK, Kaushal SS. Symmetrical peripheral gangrene due to viral gastroenteritis. THE JOURNAL OF THE ASSOCIATION OF PHYSICIANS OF INDIA 2004; 52:500-1. [PMID: 15645964] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/01/2023]
Abstract
A case of multifactorial symmetrical peripheral gangrene due to viral gastroenteritis, shock, dopamine infusion, exposure to low temperature and nonlactose fermenters septicaemia is presented for its rarity and devastating consequences.
Collapse
|
155
|
Adams J, Adler C, Aggarwal MM, Ahammed Z, Amonett J, Anderson BD, Arkhipkin D, Averichev GS, Bai Y, Balewski J, Barannikova O, Barnby LS, Baudot J, Bekele S, Belaga VV, Bellwied R, Berger J, Bezverkhny BI, Bharadwaj S, Bhatia VS, Bichsel H, Bland LC, Blyth CO, Bonner BE, Botje M, Boucham A, Brandin A, Bravar A, Cadman RV, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Carroll J, Castillo J, Cebra D, Chaloupka P, Chattopdhyay S, Chen HF, Chen Y, Cheng J, Cherney M, Chikanian A, Christie W, Coffin JP, Cormier TM, Cramer JG, Crawford HJ, Das D, Das S, de Moura MM, Derevschikov AA, Didenko L, Dietel T, Dong WJ, Dong X, Draper JE, Du F, Dubey AK, Dunin VB, Dunlop JC, Dutta Mazumdar MR, Eckardt V, Efimov LG, Emelianov V, Engelage J, Eppley G, Erazmus B, Estienne M, Fachini P, Faivre J, Fatemi R, Fedorisin J, Filimonov K, Filip P, Finch E, Fine V, Fisyak Y, Flierl D, Foley KJ, Fomenko K, Fu J, Gagliardi CA, Gans J, Ganti MS, Gaudichet L, Geurts F, Ghazikhanian V, Ghosh P, Gonzalez JE, Grachov O, Grebenyuk O, Gronstal S, Grosnick D, Guertin SM, Gupta A, Gutierrez TD, Hallman TJ, Hamed A, Hardtke D, Harris JW, Heinz M, Henry TW, Hepplemann S, Hippolyte B, Hirsch A, Hjort E, Hoffmann GW, Huang HZ, Huang SL, Hughes E, Humanic TJ, Igo G, Ishihara A, Jacobs P, Jacobs WW, Janik M, Jiang H, Jones PG, Judd EG, Kabana S, Kang K, Kaplan M, Keane D, Khodyrev VY, Kiryluk J, Kisiel A, Kislov EM, Klay J, Klein SR, Klyachko A, Koetke DD, Kollegger T, Kopytine M, Kotchenda L, Kramer M, Kravtsov P, Kravtsov VI, Krueger K, Kuhn C, Kulikov AI, Kumar A, Kunz CL, Kutuev RK, Kuznetsov AA, Lamont MAC, Landgraf JM, Lange S, Lansdell CL, Laue F, Lauret J, Lebedev A, Lednicky R, Lehocka S, LeVine MJ, Li C, Li Q, Li Y, Lindenbaum SJ, Lisa MA, Liu F, Liu L, Liu QJ, Liu Z, Ljubicic T, Llope WJ, Long H, Longacre RS, Lopez-Noriega M, Love WA, Ludlam T, Lynn D, Ma GL, Ma JG, Ma YG, Magestro D, Mahajan S, Mahapatra DP, Majka R, Mangotra LK, Manweiler R, Margetis S, Markert C, Martin L, Marx JN, Matis HS, Matulenko YA, McClain CJ, McShane TS, Meissner F, Melnick Y, Meschanin A, Miller ML, Milosevich Z, Minaev NG, Mironov C, Mischke A, Mishra D, Mitchell J, Mohanty B, Molnar L, Moore CF, Mora-Corral MJ, Morozov DA, Morozov V, Munhoz MG, Nandi BK, Nayak TK, Nelson JM, Netrakanti PK, Nikitin VA, Nogach LV, Norman B, Nurushev SB, Odyniec G, Ogawa A, Okorokov V, Oldenburg M, Olson D, Pal SK, Panebratsev Y, Panitkin SY, Pavlinov AI, Pawlak T, Peitzmann T, Perevoztchikov V, Perkins C, Peryt W, Petrov VA, Phatak SC, Picha R, Planinic M, Pluta J, Porile N, Porter J, Poskanzer AM, Potekhin M, Potrebenikova E, Potukuchi BVKS, Prindle D, Pruneau C, Putschke J, Rai G, Rakness G, Raniwala R, Raniwala S, Ravel O, Ray RL, Razin SV, Reichhold D, Reid JG, Renault G, Retiere F, Ridiger A, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Rose A, Ruan L, Sakrejda I, Salur S, Sandweiss J, Savin I, Sazhin PS, Schambach J, Scharenberg RP, Schmitz N, Schroeder LS, Schweda K, Seger J, Seyboth P, Shahaliev E, Shao M, Shao W, Sharma M, Shen WQ, Shestermanov KE, Shimanskiy SS, Simon F, Singaraju RN, Skoro G, Smirnov N, Snellings R, Sood G, Sorensen P, Sowinski J, Speltz J, Spinka HM, Srivastava B, St Claire L, Stadnik A, Stock R, Stolpovsky A, Strikhanov M, Stringfellow B, Struck C, Suaide AAP, Sugarbaker E, Suire C, Sumbera M, Surrow B, Symons TJM, Szanto de Toledo A, Szarwas P, Tai A, Takahashi J, Tang AH, Thein D, Thomas JH, Timoshenko S, Tokarev M, Trainor TA, Trentalange S, Tribble RE, Tsai O, Ullrich T, Underwood DG, Urkinbaev A, Van Buren G, Vander Molen AM, Varma R, Vasilevski IM, Vasiliev AN, Vernet R, Vigdor SE, Viyogi VP, Vokal S, Vznuzdaev M, Waggoner B, Wang F, Wang G, Wang G, Wang XL, Wang Y, Wang Y, Wang ZM, Ward H, Webb JC, Wells R, Westfall GD, Wetzler A, Whitten C, Wieman H, Wissink SW, Witt R, Wood J, Wu J, Xu N, Xu Z, Xu Z, Yamamoto E, Yepes P, Yurevich VI, Zanevsky YV, Zhang H, Zhang ZP, Zolnierczuk PA, Zoulkarneev R, Zoulkarneeva Y, Zubarev AN. Multistrange baryon production in Au-Au collisions at sqrt[s(NN)]=130 GeV. PHYSICAL REVIEW LETTERS 2004; 92:182301. [PMID: 15169485 DOI: 10.1103/physrevlett.92.182301] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/30/2003] [Indexed: 05/24/2023]
Abstract
The transverse mass spectra and midrapidity yields for Xis and Omegas are presented. For the 10% most central collisions, the (-)Xi(+)/h(-) ratio increases from the Super Proton Synchrotron to the Relativistic Heavy Ion Collider energies while the Xi(-)/h(-) stays approximately constant. A hydrodynamically inspired model fit to the Xi spectra, which assumes a thermalized source, seems to indicate that these multistrange particles experience a significant transverse flow effect, but are emitted when the system is hotter and the flow is smaller than values obtained from a combined fit to pi, K, p, and Lambdas.
Collapse
|
156
|
Adams J, Adler C, Aggarwal MM, Ahammed Z, Amonett J, Anderson BD, Anderson M, Arkhipkin D, Averichev GS, Badyal SK, Balewski J, Barannikova O, Barnby LS, Baudot J, Bekele S, Belaga VV, Bellwied R, Berger J, Bezverkhny BI, Bhardwaj S, Bhaskar P, Bhati AK, Bichsel H, Billmeier A, Bland LC, Blyth CO, Bonner BE, Botje M, Boucham A, Brandin A, Bravar A, Cadman RV, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Carroll J, Castillo J, Castro M, Cebra D, Chaloupka P, Chattopadhyay S, Chen HF, Chen Y, Chernenko SP, Cherney M, Chikanian A, Choi B, Christie W, Coffin JP, Cormier TM, Cramer JG, Crawford HJ, Das D, Das S, Derevschikov AA, Didenko L, Dietel T, Dong WJ, Dong X, Draper JE, Du F, Dubey AK, Dunin VB, Dunlop JC, Dutta Majumdar MR, Eckardt V, Efimov LG, Emelianov V, Engelage J, Eppley G, Erazmus B, Estienne M, Fachini P, Faine V, Faivre J, Fatemi R, Filimonov K, Filip P, Finch E, Fisyak Y, Flierl D, Foley KJ, Fu J, Gagliardi CA, Gagunashvili N, Gans J, Ganti MS, Gaudichet L, Germain M, Geurts F, Ghazikhanian V, Ghosh P, Gonzalez JE, Grachov O, Grigoriev V, Gronstal S, Grosnick D, Guedon M, Guertin SM, Gupta A, Gushin E, Gutierrez TD, Hallman TJ, Hardtke D, Harris JW, Heinz M, Henry TW, Heppelmann S, Herston T, Hippolyte B, Hirsch A, Hjort E, Hoffmann GW, Horsley M, Huang HZ, Huang SL, Humanic TJ, Igo G, Ishihara A, Jacobs P, Jacobs WW, Janik M, Jiang H, Johnson I, Jones PG, Judd EG, Kabana S, Kaneta M, Kaplan M, Keane D, Khodyrev VY, Kiryluk J, Kisiel A, Klay J, Klein SR, Klyachko A, Koetke DD, Kollegger T, Kopytine M, Kotchenda L, Kovalenko AD, Kramer M, Kravtsov P, Kravtsov VI, Krueger K, Kuhn C, Kulikov AI, Kumar A, Kunde GJ, Kunz CL, Kutuev RK, Kuznetsov AA, Lamont MAC, Landgraf JM, Lange S, Lansdell CP, Lasiuk B, Laue F, Lauret J, Lebedev A, Lednický R, LeVine MJ, Li C, Li Q, Lindenbaum SJ, Lisa MA, Liu F, Liu L, Liu Z, Liu QJ, Ljubicic T, Llope WJ, Long H, Longacre RS, Lopez-Noriega M, Love WA, Ludlam T, Lynn D, Ma J, Ma YG, Magestro D, Mahajan S, Mangotra LK, Mahapatra DP, Majka R, Manweiler R, Margetis S, Markert C, Martin L, Marx J, Matis HS, Matulenko YA, McShane TS, Meissner F, Melnick Y, Meschanin A, Messer M, Miller ML, Milosevich Z, Minaev NG, Mironov C, Mishra D, Mitchell J, Mohanty B, Molnar L, Moore CF, Mora-Corral MJ, Morozov DA, Morozov V, de Moura MM, Munhoz MG, Nandi BK, Nayak SK, Nayak TK, Nelson JM, Nevski P, Nikitin VA, Nogach LV, Norman B, Nurushev SB, Odyniec G, Ogawa A, Okorokov V, Oldenburg M, Olson D, Paic G, Pandey SU, Pal SK, Panebratsev Y, Panitkin SY, Pavlinov AI, Pawlak T, Perevoztchikov V, Perkins C, Peryt W, Petrov VA, Phatak SC, Picha R, Planinic M, Pluta J, Porile N, Porter J, Poskanzer AM, Potekhin M, Potrebenikova E, Potukuchi BVKS, Prindle D, Pruneau C, Putschke J, Rai G, Rakness G, Raniwala R, Raniwala S, Ravel O, Ray RL, Razin SV, Reichhold D, Reid JG, Renault G, Retiere F, Ridiger A, Ritter HG, Roberts JB, Rogachevski OV, Romero JL, Rose A, Roy C, Ruan LJ, Sahoo R, Sakrejda I, Salur S, Sandweiss J, Savin I, Schambach J, Scharenberg RP, Schmitz N, Schroeder LS, Schweda K, Seger J, Seliverstov D, Seyboth P, Shahaliev E, Shao M, Sharma M, Shestermanov KE, Shimanskii SS, Singaraju RN, Simon F, Skoro G, Smirnov N, Snellings R, Sood G, Sorensen P, Sowinski J, Spinka HM, Srivastava B, Stanislaus S, Stock R, Stolpovsky A, Strikhanov M, Stringfellow B, Struck C, Suaide AAP, Sugarbaker E, Suire C, Sumbera M, Surrow B, Symons TJM, Szanto de Toledo A, Szarwas P, Tai A, Takahashi J, Tang AH, Thein D, Thomas JH, Tikhomirov V, Tokarev M, Tonjes MB, Trainor TA, Trentalange S, Tribble RE, Trivedi MD, Trofimov V, Tsai O, Ullrich T, Underwood DG, Van Buren G, VanderMolen AM, Vasiliev AN, Vasiliev M, Vigdor SE, Viyogi YP, Voloshin SA, Waggoner W, Wang F, Wang G, Wang XL, Wang ZM, Ward H, Watson JW, Wells R, Westfall GD, Whitten C, Wieman H, Willson R, Wissink SW, Witt R, Wood J, Wu J, Xu N, Xu Z, Xu ZZ, Yamamoto E, Yepes P, Yurevich VI, Zanevski YV, Zborovský I, Zhang H, Zhang WM, Zhang ZP, Zołnierczuk PA, Zoulkarneev R, Zoulkarneeva J, Zubarev AN. Cross sections and transverse single-spin asymmetries in forward neutral-pion production from proton collisions at sqrt[s]=200 GeV. PHYSICAL REVIEW LETTERS 2004; 92:171801. [PMID: 15169138 DOI: 10.1103/physrevlett.92.171801] [Citation(s) in RCA: 41] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/03/2003] [Indexed: 05/24/2023]
Abstract
Measurements of the production of forward high-energy pi(0) mesons from transversely polarized proton collisions at sqrt[s]=200 GeV are reported. The cross section is generally consistent with next-to-leading order perturbative QCD calculations. The analyzing power is small at x(F) below about 0.3, and becomes positive and large at higher x(F), similar to the trend in data at sqrt[s]< or =20 GeV. The analyzing power is in qualitative agreement with perturbative QCD model expectations. This is the first significant spin result seen for particles produced with p(T)>1 GeV/c at a polarized proton collider.
Collapse
|
157
|
Nischal KC, Sachdev D, Kharkar V, Mahajan S. Juvenile hyaline fibromatosis. J Postgrad Med 2004; 50:125-6. [PMID: 15235211] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/30/2023] Open
|
158
|
Adams J, Adler C, Aggarwal MM, Ahammed Z, Amonett J, Anderson BD, Anderson M, Arkhipkin D, Averichev GS, Badyal SK, Balewski J, Barannikova O, Barnby LS, Baudot J, Bekele S, Belaga VV, Bellwied R, Berger J, Bezverkhny BI, Bhardwaj S, Bhaskar P, Bhati AK, Bichsel H, Billmeier A, Bland LC, Blyth CO, Bonner BE, Botje M, Boucham A, Brandin A, Bravar A, Cadman RV, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Carroll J, Castillo J, Castro M, Cebra D, Chaloupka P, Chattopadhyay S, Chen HF, Chen Y, Chernenko SP, Cherney M, Chikanian A, Choi B, Christie W, Coffin JP, Cormier TM, Cramer JG, Crawford HJ, Das D, Das S, Derevschikov AA, Didenko L, Dietel T, Dong X, Draper JE, Du F, Dubey AK, Dunin VB, Dunlop JC, Dutta Majumdar MR, Eckardt V, Efimov LG, Emelianov V, Engelage J, Eppley G, Erazmus B, Estienne M, Fachini P, Faine V, Faivre J, Fatemi R, Filimonov K, Filip P, Finch E, Fisyak Y, Flierl D, Foley KJ, Fu J, Gagliardi CA, Ganti MS, Gutierrez TD, Gagunashvili N, Gans J, Gaudichet L, Germain M, Geurts F, Ghazikhanian V, Ghosh P, Gonzalez JE, Grachov O, Grigoriev V, Gronstal S, Grosnick D, Guedon M, Guertin SM, Gupta A, Gushin E, Hallman TJ, Hardtke D, Harris JW, Heinz M, Henry TW, Heppelmann S, Herston T, Hippolyte B, Hirsch A, Hjort E, Hoffmann GW, Horsley M, Huang HZ, Huang SL, Humanic TJ, Igo G, Ishihara A, Jacobs P, Jacobs WW, Janik M, Johnson I, Jones PG, Judd EG, Kabana S, Kaneta M, Kaplan M, Keane D, Kiryluk J, Kisiel A, Klay J, Klein SR, Klyachko A, Koetke DD, Kollegger T, Konstantinov AS, Kopytine M, Kotchenda L, Kovalenko AD, Kramer M, Kravtsov P, Krueger K, Kuhn C, Kulikov AI, Kumar A, Kunde GJ, Kunz CL, Kutuev RK, Kuznetsov AA, Lamont MAC, Landgraf JM, Lange S, Lansdell CP, Lasiuk B, Laue F, Lauret J, Lebedev A, Lednický R, Leontiev VM, LeVine MJ, Li C, Li Q, Lindenbaum SJ, Lisa MA, Liu F, Liu L, Liu Z, Liu QJ, Ljubicic T, Llope WJ, Long H, Longacre RS, Lopez-Noriega M, Love WA, Ludlam T, Lynn D, Ma J, Ma YG, Magestro D, Mahajan S, Mangotra LK, Mahapatra DP, Majka R, Manweiler R, Margetis S, Markert C, Martin L, Marx J, Matis HS, Matulenko YA, McShane TS, Meissner F, Melnick Y, Meschanin A, Messer M, Miller ML, Milosevich Z, Minaev NG, Mironov C, Mishra D, Mitchell J, Mohanty B, Molnar L, Moore CF, Mora-Corral MJ, Morozov V, de Moura MM, Munhoz MG, Nandi BK, Nayak SK, Nayak TK, Nelson JM, Nevski P, Nikitin VA, Nogach LV, Norman B, Nurushev SB, Odyniec G, Ogawa A, Okorokov V, Oldenburg M, Olson D, Paic G, Pandey SU, Pal SK, Panebratsev Y, Panitkin SY, Pavlinov AI, Pawlak T, Perevoztchikov V, Peryt W, Petrov VA, Phatak SC, Picha R, Planinic M, Pluta J, Porile N, Porter J, Poskanzer AM, Potekhin M, Potrebenikova E, Potukuchi BVKS, Prindle D, Pruneau C, Putschke J, Rai G, Rakness G, Raniwala R, Raniwala S, Ravel O, Ray RL, Razin SV, Reichhold D, Reid JG, Renault G, Retiere F, Ridiger A, Ritter HG, Roberts JB, Rogachevski OV, Romero JL, Rose A, Roy C, Ruan LJ, Sahoo R, Sakrejda I, Salur S, Sandweiss J, Savin I, Schambach J, Scharenberg RP, Schmitz N, Schroeder LS, Schweda K, Seger J, Seliverstov D, Seyboth P, Shahaliev E, Shao M, Sharma M, Shestermanov KE, Shimanskii SS, Singaraju RN, Simon F, Skoro G, Smirnov N, Snellings R, Sood G, Sorensen P, Sowinski J, Spinka HM, Srivastava B, Stanislaus S, Stock R, Stolpovsky A, Strikhanov M, Stringfellow B, Struck C, Suaide AAP, Sugarbaker E, Suire C, Sumbera M, Surrow B, Symons TJM, de Toledo AS, Szarwas P, Tai A, Takahashi J, Tang AH, Thein D, Thomas JH, Tikhomirov V, Tokarev M, Tonjes MB, Trainor TA, Trentalange S, Tribble RE, Trivedi MD, Trofimov V, Tsai O, Ullrich T, Underwood DG, Van Buren G, VanderMolen AM, Vasiliev AN, Vasiliev M, Vigdor SE, Viyogi YP, Voloshin SA, Waggoner W, Wang F, Wang G, Wang XL, Wang ZM, Ward H, Watson JW, Wells R, Westfall GD, Whitten C, Wieman H, Willson R, Wissink SW, Witt R, Wood J, Wu J, Xu N, Xu Z, Xu ZZ, Yakutin AE, Yamamoto E, Yang J, Yepes P, Yurevich VI, Zanevski YV, Zborovský I, Zhang H, Zhang HY, Zhang WM, Zhang ZP, Zołnierczuk PA, Zoulkarneev R, Zoulkarneeva J, Zubarev AN. Identified particle distributions in pp and Au+Au collisions at square root of (sNN)=200 GeV. PHYSICAL REVIEW LETTERS 2004; 92:112301. [PMID: 15089125 DOI: 10.1103/physrevlett.92.112301] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/02/2003] [Indexed: 05/24/2023]
Abstract
Transverse mass and rapidity distributions for charged pions, charged kaons, protons, and antiprotons are reported for square root of [sNN]=200 GeV pp and Au+Au collisions at Relativistic Heary Ion Collider (RHIC). Chemical and kinetic equilibrium model fits to our data reveal strong radial flow and long duration from chemical to kinetic freeze-out in central Au+Au collisions. The chemical freeze-out temperature appears to be independent of initial conditions at RHIC energies.
Collapse
|
159
|
Adams J, Adler C, Aggarwal MM, Ahammed Z, Amonett J, Anderson BD, Arkhipkin D, Averichev GS, Badyal SK, Balewski J, Barannikova O, Barnby LS, Baudot J, Bekele S, Belaga VV, Bellwied R, Berger J, Bezverkhny BI, Bhardwaj S, Bhati AK, Bichsel H, Billmeier A, Bland LC, Blyth CO, Bonner BE, Botje M, Boucham A, Brandin A, Bravar A, Cadman RV, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Carroll J, Castillo J, Cebra D, Chaloupka P, Chattopadhyay S, Chen HF, Chen Y, Chernenko SP, Cherney M, Chikanian A, Christie W, Coffin JP, Cormier TM, Cramer JG, Crawford HJ, Das D, Das S, Derevschikov AA, Didenko L, Dietel T, Dong WJ, Dong X, Draper JE, Du F, Dubey AK, Dunin VB, Dunlop JC, Dutta Majumdar MR, Eckardt V, Efimov LG, Emelianov V, Engelage J, Eppley G, Erazmus B, Estienne M, Fachini P, Faine V, Faivre J, Fatemi R, Filimonov K, Filip P, Finch E, Fisyak Y, Flierl D, Foley KJ, Fu J, Gagliardi CA, Gagunashvili N, Gans J, Ganti MS, Gaudichet L, Geurts F, Ghazikhanian V, Ghosh P, Gonzalez JE, Grachov O, Grebenyuk O, Gronstal S, Grosnick D, Guertin SM, Gupta A, Gutierrez TD, Hallman TJ, Hamed A, Hardtke D, Harris JW, Heinz M, Henry TW, Heppelmann S, Hippolyte B, Hirsch A, Hjort E, Hoffmann GW, Horsley M, Huang HZ, Huang SL, Hughes E, Humanic TJ, Igo G, Ishihara A, Jacobs P, Jacobs WW, Janik M, Jiang H, Johnson I, Jones PG, Judd EG, Kabana S, Kaplan M, Keane D, Khodyrev VY, Kiryluk J, Kisiel A, Klay J, Klein SR, Klyachko A, Koetke DD, Kollegger T, Kopytine M, Kotchenda L, Kovalenko AD, Kramer M, Kravtsov P, Kravtsov VI, Krueger K, Kuhn C, Kulikov AI, Kumar A, Kunde GJ, Kunz CL, Kutuev RK, Kuznetsov AA, Lamont MAC, Landgraf JM, Lange S, Lasiuk B, Laue F, Lauret J, Lebedev A, Lednický R, LeVine MJ, Li C, Li Q, Lindenbaum SJ, Lisa MA, Liu F, Liu L, Liu Z, Liu QJ, Ljubicic T, Llope WJ, Long H, Longacre RS, Lopez-Noriega M, Love WA, Ludlam T, Lynn D, Ma J, Ma YG, Magestro D, Mahajan S, Mangotra LK, Mahapatra DP, Majka R, Manweiler R, Margetis S, Markert C, Martin L, Marx J, Matis HS, Matulenko YA, McClain CJ, McShane TS, Meissner F, Melnick Y, Meschanin A, Miller ML, Milosevich Z, Minaev NG, Mironov C, Mischke A, Mishra D, Mitchell J, Mohanty B, Molnar L, Moore CF, Mora-Corral MJ, Morozov DA, Morozov V, De Moura MM, Munhoz MG, Nandi BK, Nayak SK, Nayak TK, Nelson JM, Netrakanti PK, Nikitin VA, Nogach LV, Norman B, Nurushev SB, Odyniec G, Ogawa A, Okorokov V, Oldenburg M, Olson D, Paic G, Pal SK, Panebratsev Y, Panitkin SY, Pavlinov AI, Pawlak T, Peitzmann T, Perevoztchikov V, Perkins C, Peryt W, Petrov VA, Phatak SC, Picha R, Planinic M, Pluta J, Porile N, Porter J, Poskanzer AM, Potekhin M, Potrebenikova E, Potukuchi BVKS, Prindle D, Pruneau C, Putschke J, Rai G, Rakness G, Raniwala R, Raniwala S, Ravel O, Ray RL, Razin SV, Reichhold D, Reid JG, Renault G, Retiere F, Ridiger A, Ritter HG, Roberts JB, Rogachevski OV, Romero JL, Rose A, Roy C, Ruan LJ, Sahoo R, Sakrejda I, Salur S, Sandweiss J, Savin I, Schambach J, Scharenberg RP, Schmitz N, Schroeder LS, Schweda K, Seger J, Seyboth P, Shahaliev E, Shao M, Shao W, Sharma M, Shestermanov KE, Shimanskii SS, Singaraju RN, Simon F, Skoro G, Smirnov N, Snellings R, Sood G, Sorensen P, Sowinski J, Speltz J, Spinka HM, Srivastava B, Stanislaus TDS, Stock R, Stolpovsky A, Strikhanov M, Stringfellow B, Struck C, Suaide AAP, Sugarbaker E, Suire C, Sumbera M, Surrow B, Symons TJM, Szanto de Toledo A, Szarwas P, Tai A, Takahashi J, Tang AH, Thein D, Thomas JH, Timoshenko S, Tokarev M, Tonjes MB, Trainor TA, Trentalange S, Tribble RE, Tsai O, Ullrich T, Underwood DG, Van Buren G, VanderMolen AM, Varma R, Vasilevski I, Vasiliev AN, Vernet R, Vigdor SE, Viyogi YP, Voloshin SA, Vznuzdaev M, Waggoner W, Wang F, Wang G, Wang G, Wang XL, Wang Y, Wang ZM, Ward H, Watson JW, Webb JC, Wells R, Westfall GD, Whitten C, Wieman H, Willson R, Wissink SW, Witt R, Wood J, Wu J, Xu N, Xu Z, Xu ZZ, Yamamoto E, Yepes P, Yurevich VI, Yuting B, Zanevski YV, Zhang H, Zhang WM, Zhang ZP, Zhaomin ZP, Zizong ZP, Zołnierczuk PA, Zoulkarneev R, Zoulkarneeva J, Zubarev AN. Rho0 production and possible modification in Au+Au and p+p collisions at square root [sNN] = 200 GeV. PHYSICAL REVIEW LETTERS 2004; 92:092301. [PMID: 15089460 DOI: 10.1103/physrevlett.92.092301] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/28/2003] [Indexed: 05/24/2023]
Abstract
We report results on rho(770)(0)-->pi(+)pi(-) production at midrapidity in p+p and peripheral Au+Au collisions at sqrt[s(NN)]=200 GeV. This is the first direct measurement of rho(770)(0)-->pi(+)pi(-) in heavy-ion collisions. The measured rho(0) peak in the invariant mass distribution is shifted by approximately 40 MeV/c(2) in minimum bias p+p interactions and approximately 70 MeV/c(2) in peripheral Au+Au collisions. The rho(0) mass shift is dependent on transverse momentum and multiplicity. The modification of the rho(0) meson mass, width, and shape due to phase space and dynamical effects are discussed.
Collapse
|
160
|
Mahajan S, Koranne RV, Sardana K, Mendiratta V, Damani A. Perforating folliculitis with jaundice in an Indian male: a rare case with sclerosing cholangitis. Br J Dermatol 2004; 150:614-6. [PMID: 15030363 DOI: 10.1046/j.1365-2133.2004.05812.x] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
161
|
Adams J, Adler C, Aggarwal MM, Ahammed Z, Amonett J, Anderson BD, Anderson M, Arkhipkin D, Averichev GS, Badyal SK, Balewski J, Barannikova O, Barnby LS, Baudot J, Bekele S, Belaga VV, Bellwied R, Berger J, Bezverkhny BI, Bhardwaj S, Bhaskar P, Bhati AK, Bichsel H, Billmeier A, Bland LC, Blyth CO, Bonner BE, Botje M, Boucham A, Brandin A, Bravar A, Cadman RV, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Carroll J, Castillo J, Castro M, Cebra D, Chaloupka P, Chattopadhyay S, Chen HF, Chen Y, Chernenko SP, Cherney M, Chikanian A, Choi B, Christie W, Coffin JP, Cormier TM, Cramer JG, Crawford HJ, Das D, Das S, Derevschikov AA, Didenko L, Dietel T, Dong WJ, Dong X, Draper JE, Du F, Dubey AK, Dunin VB, Dunlop JC, Dutta Majumdar MR, Eckardt V, Efimov LG, Emelianov V, Engelage J, Eppley G, Erazmus B, Estienne M, Fachini P, Faine V, Faivre J, Fatemi R, Filimonov K, Filip P, Finch E, Fisyak Y, Flierl D, Foley KJ, Fu J, Gagliardi CA, Gagunashvili N, Gans J, Ganti MS, Gaudichet L, Germain M, Geurts F, Ghazikhanian V, Ghosh P, Gonzalez JE, Grachov O, Grigoriev V, Gronstal S, Grosnick D, Guedon M, Guertin SM, Gupta A, Gushin E, Gutierrez TD, Hallman TJ, Hardtke D, Harris JW, Heinz M, Henry TW, Heppelmann S, Herston T, Hippolyte B, Hirsch A, Hjort E, Hoffmann GW, Horsley M, Huang HZ, Huang SL, Humanic TJ, Igo G, Ishihara A, Jacobs P, Jacobs WW, Janik M, Jiang H, Johnson I, Jones PG, Judd EG, Kabana S, Kaneta M, Kaplan M, Keane D, Khodyrev VY, Kiryluk J, Kisiel A, Klay J, Klein SR, Klyachko A, Koetke DD, Kollegger T, Kopytine M, Kotchenda L, Kovalenko AD, Kramer M, Kravtsov P, Kravtsov VI, Krueger K, Kuhn C, Kulikov AI, Kumar A, Kunde GJ, Kunz CL, Kutuev RK, Kuznetsov AA, Lamont MAC, Landgraf JM, Lange S, Lansdell CP, Lasiuk B, Laue F, Lauret J, Lebedev A, Lednický R, LeVine MJ, Li C, Li Q, Lindenbaum SJ, Lisa MA, Liu F, Liu L, Liu Z, Liu QJ, Ljubicic T, Llope WJ, Long H, Longacre RS, Lopez-Noriega M, Love WA, Ludlam T, Lynn D, Ma J, Ma YG, Magestro D, Mahajan S, Mangotra LK, Mahapatra DP, Majka R, Manweiler R, Margetis S, Markert C, Martin L, Marx J, Matis HS, Matulenko YA, McShane TS, Meissner F, Melnick Y, Meschanin A, Messer M, Miller ML, Milosevich Z, Minaev NG, Mironov C, Mishra D, Mitchell J, Mohanty B, Molnar L, Moore CF, Mora-Corral MJ, Morozov DA, Morozov V, de Moura MM, Munhoz MG, Nandi BK, Nayak SK, Nayak TK, Nelson JM, Nevski P, Nikitin VA, Nogach LV, Norman B, Nurushev SB, Odyniec G, Ogawa A, Okorokov V, Oldenburg M, Olson D, Paic G, Pandey SU, Pal SK, Panebratsev Y, Panitkin SY, Pavlinov AI, Pawlak T, Perevoztchikov V, Perkins C, Peryt W, Petrov VA, Phatak SC, Picha R, Planinic M, Pluta J, Porile N, Porter J, Poskanzer AM, Potekhin M, Potrebenikova E, Potukuchi BVKS, Prindle D, Pruneau C, Putschke J, Rai G, Rakness G, Raniwala R, Raniwala S, Ravel O, Ray RL, Razin SV, Reichhold D, Reid JG, Renault G, Retiere F, Ridiger A, Ritter HG, Roberts JB, Rogachevski OV, Romero JL, Rose A, Roy C, Ruan LJ, Sahoo R, Sakrejda I, Salur S, Sandweiss J, Savin I, Schambach J, Scharenberg RP, Schmitz N, Schroeder LS, Schweda K, Seger J, Seliverstov D, Seyboth P, Shahaliev E, Shao M, Sharma M, Shestermanov KE, Shimanskii SS, Singaraju RN, Simon F, Skoro G, Smirnov N, Snellings R, Sood G, Sorensen P, Sowinski J, Spinka HM, Srivastava B, Stanislaus S, Stock R, Stolpovsky A, Strikhanov M, Stringfellow B, Struck C, Suaide AAP, Sugarbaker E, Suire C, Sumbera M, Surrow B, Symons TJM, de Toledo AS, Szarwas P, Tai A, Takahashi J, Tang AH, Thein D, Thomas JH, Tikhomirov V, Tokarev M, Tonjes MB, Trainor TA, Trentalange S, Tribble RE, Trivedi MD, Trofimov V, Tsai O, Ullrich T, Underwood DG, Van Buren G, VanderMolen AM, Vasiliev AN, Vasiliev M, Vigdor SE, Viyogi YP, Voloshin SA, Waggoner W, Wang F, Wang G, Wang XL, Wang ZM, Ward H, Watson JW, Wells R, Westfall GD, Whitten C, Wieman H, Willson R, Wissink SW, Witt R, Wood J, Wu J, Xu N, Xu Z, Xu ZZ, Yamamoto E, Yepes P, Yurevich VI, Zanevski YV, Zborovský I, Zhang H, Zhang WM, Zhang ZP, Zołnierczuk PA, Zoulkarneev R, Zoulkarneeva J, Zubarev AN. Azimuthal anisotropy at the relativistic heavy ion collider: the first and fourth harmonics. PHYSICAL REVIEW LETTERS 2004; 92:062301. [PMID: 14995231 DOI: 10.1103/physrevlett.92.062301] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/28/2003] [Indexed: 05/24/2023]
Abstract
We report the first observations of the first harmonic (directed flow, v(1)) and the fourth harmonic (v(4)), in the azimuthal distribution of particles with respect to the reaction plane in Au+Au collisions at the BNL Relativistic Heavy Ion Collider (RHIC). Both measurements were done taking advantage of the large elliptic flow (v(2)) generated at RHIC. From the correlation of v(2) with v(1) it is determined that v(2) is positive, or in-plane. The integrated v(4) is about a factor of 10 smaller than v(2). For the sixth (v(6)) and eighth (v(8)) harmonics upper limits on the magnitudes are reported.
Collapse
|
162
|
Ong GM, Lowry K, Mahajan S, Wyatt DE, Simpson C, O'Neill HJ, McCaughey C, Coyle PV. Herpes simplex type 1 shedding is associated with reduced hospital survival in patients receiving assisted ventilation in a tertiary referral intensive care unit. J Med Virol 2004; 72:121-5. [PMID: 14635019 DOI: 10.1002/jmv.10524] [Citation(s) in RCA: 55] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
The impact of shedding of herpes simplex virus type 1 (HSV-1) on hospital survival of patients receiving assisted ventilation in an adult tertiary referral, acute trauma intensive care unit was assessed. The study was designed to address a clinical impression linking HSV-1 recovery with poor survival. Two hundred and forty-one males and 152 females were enrolled into a longitudinal cohort study. Combined throat swabs and tracheal secretions were tested for HSV-1 shedding using a nested nucleic acid amplification protocol; patients were ranked as nonshedders, shedders, and high-level shedders. Nonparametric analysis assessed the impact of shedding on hospital survival and logistic regression measured the confounding influence of sex, age, and the Acute Physiology, Age and Chronic Health Evaluation (APACHE II) score. Linear-by-linear association determined the influence of the level of shedding on hospital survival. The observed mortality rate was 113/393 (28.8%). Patients shedding HSV-1 106/393 (27%) had a significant reduction in hospital survival 66/106 (62%) in HSV-1 shedders compared with 217/287 (75.6%) in nonshedders (P = 0.002). This difference remained significant when adjusted for age and sex (P = 0.026). Respective mortality figures for HSV-1 shedders and nonshedders were 43/106 (40.6%) and 70/287 (24.4%) (P = 0.002). HSV-1 shedding was associated with a significant reduction in hospital survival amongst patients receiving assisted ventilation. Hospital mortality in HSV-1 shedders was increased by 16.2% over nonshedders. The role of HSV-1 in this setting needs to be addressed.
Collapse
|
163
|
Adams J, Adler C, Aggarwal MM, Ahammed Z, Amonett J, Anderson BD, Anderson M, Arkhipkin D, Averichev GS, Badyal SK, Balewski J, Barannikova O, Barnby LS, Baudot J, Bekele S, Belaga VV, Bellwied R, Berger J, Bezverkhny BI, Bhardwaj S, Bhaskar P, Bhati AK, Bichsel H, Billmeier A, Bland LC, Blyth CO, Bonner BE, Botje M, Boucham A, Brandin A, Bravar A, Cadman RV, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Carroll J, Castillo J, Castro M, Cebra D, Chaloupka P, Chattopadhyay S, Chen HF, Chen Y, Chernenko SP, Cherney M, Chikanian A, Choi B, Christie W, Coffin JP, Cormier TM, Cramer JG, Crawford HJ, Das D, Das S, Derevschikov AA, Didenko L, Dietel T, Dong WJ, Dong X, Draper JE, Du F, Dubey AK, Dunin VB, Dunlop JC, Dutta Majumdar MR, Eckardt V, Efimov LG, Emelianov V, Engelage J, Eppley G, Erazmus B, Estienne M, Fachini P, Faine V, Faivre J, Fatemi R, Filimonov K, Filip P, Finch E, Fisyak Y, Flierl D, Foley KJ, Fu J, Gagliardi CA, Gagunashvili N, Gans J, Ganti MS, Gaudichet L, Germain M, Geurts F, Ghazikhanian V, Ghosh P, Gonzalez JE, Grachov O, Grigoriev V, Gronstal S, Grosnick D, Guedon M, Guertin SM, Gupta A, Gushin E, Gutierrez TD, Hallman TJ, Hardtke D, Harris JW, Heinz M, Henry TW, Heppelmann S, Herston T, Hippolyte B, Hirsch A, Hjort E, Hoffmann GW, Horsley M, Huang HZ, Huang SL, Humanic TJ, Igo G, Ishihara A, Jacobs P, Jacobs WW, Janik M, Jiang H, Johnson I, Jones PG, Judd EG, Kabana S, Kaneta M, Kaplan M, Keane D, Khodyrev VY, Kiryluk J, Kisiel A, Klay J, Klein SR, Klyachko A, Koetke DD, Kollegger T, Kopytine M, Kotchenda L, Kovalenko AD, Kramer M, Kravtsov P, Kravtsov VI, Krueger K, Kuhn C, Kulikov AI, Kumar A, Kunde GJ, Kunz CL, Kutuev RK, Kuznetsov AA, Lamont MAC, Landgraf JM, Lange S, Lansdell CP, Lasiuk B, Laue F, Lauret J, Lebedev A, Lednický R, LeVine MJ, Li C, Li Q, Lindenbaum SJ, Lisa MA, Liu F, Liu L, Liu Z, Liu QJ, Ljubicic T, Llope WJ, Long H, Longacre RS, Lopez-Noriega M, Love WA, Ludlam T, Lynn D, Ma J, Ma YG, Magestro D, Mahajan S, Mangotra LK, Mahapatra DP, Majka R, Manweiler R, Margetis S, Markert C, Martin L, Marx J, Matis HS, Matulenko YA, McShane TS, Meissner F, Melnick Y, Meschanin A, Messer M, Miller ML, Milosevich Z, Minaev NG, Mironov C, Mishra D, Mitchell J, Mohanty B, Molnar L, Moore CF, Mora-Corral MJ, Morozov DA, Morozov V, de Moura MM, Munhoz MG, Nandi BK, Nayak SK, Nayak TK, Nelson JM, Nevski P, Nikitin VA, Nogach LV, Norman B, Nurushev SB, Odyniec G, Ogawa A, Okorokov V, Oldenburg M, Olson D, Paic G, Pandey SU, Pal SK, Panebratsev Y, Panitkin SY, Pavlinov AI, Pawlak T, Perevoztchikov V, Perkins C, Peryt W, Petrov VA, Phatak SC, Picha R, Planinic M, Pluta J, Porile N, Porter J, Poskanzer AM, Potekhin M, Potrebenikova E, Potukuchi BVKS, Prindle D, Pruneau C, Putschke J, Rai G, Rakness G, Raniwala R, Raniwala S, Ravel O, Ray RL, Razin SV, Reichhold D, Reid JG, Renault G, Retiere F, Ridiger A, Ritter HG, Roberts JB, Rogachevski OV, Romero JL, Rose A, Roy C, Ruan LJ, Sahoo R, Sakrejda I, Salur S, Sandweiss J, Savin I, Schambach J, Scharenberg RP, Schmitz N, Schroeder LS, Schweda K, Seger J, Seliverstov D, Seyboth P, Shahaliev E, Shao M, Sharma M, Shestermanov KE, Shimanskii SS, Singaraju RN, Simon F, Skoro G, Smirnov N, Snellings R, Sood G, Sorensen P, Sowinski J, Spinka HM, Srivastava B, Stanislaus S, Stock R, Stolpovsky A, Strikhanov M, Stringfellow B, Struck C, Suaide AAP, Sugarbaker E, Suire C, Sumbera M, Surrow B, Symons TJM, de Toledo AS, Szarwas P, Tai A, Takahashi J, Tang AH, Thein D, Thomas JH, Tikhomirov V, Tokarev M, Tonjes MB, Trainor TA, Trentalange S, Tribble RE, Trivedi MD, Trofimov V, Tsai O, Ullrich T, Underwood DG, Van Buren G, VanderMolen AM, Vasiliev AN, Vasiliev M, Vigdor SE, Viyogi YP, Voloshin SA, Waggoner W, Wang F, Wang G, Wang XL, Wang ZM, Ward H, Watson JW, Wells R, Westfall GD, Whitten C, Wieman H, Willson R, Wissink SW, Witt R, Wood J, Wu J, Xu N, Xu Z, Xu ZZ, Yamamoto E, Yepes P, Yurevich VI, Zanevski YV, Zborovský I, Zhang H, Zhang WM, Zhang ZP, Zołnierczuk PA, Zoulkarneev R, Zoulkarneeva J, Zubarev AN. Particle-type dependence of azimuthal anisotropy and nuclear modification of particle production in Au+Au collisions at square root of sNN=200 GeV. PHYSICAL REVIEW LETTERS 2004; 92:052302. [PMID: 14995300 DOI: 10.1103/physrevlett.92.052302] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/03/2003] [Indexed: 05/24/2023]
Abstract
We present STAR measurements of the azimuthal anisotropy parameter v(2) and the binary-collision scaled centrality ratio R(CP) for kaons and lambdas (Lambda+Lambda) at midrapidity in Au+Au collisions at square root of s(NN)=200 GeV. In combination, the v(2) and R(CP) particle-type dependencies contradict expectations from partonic energy loss followed by standard fragmentation in vacuum. We establish p(T) approximately 5 GeV/c as the value where the centrality dependent baryon enhancement ends. The K(0)(S) and Lambda+Lambda v(2) values are consistent with expectations of constituent-quark-number scaling from models of hadron formation by parton coalescence or recombination.
Collapse
|
164
|
Nair MPN, Mahajan S, Hewitt R, Whitney ZRB, Schwartz SA. Association of drug abuse with inhibition of HIV-1 immune responses: studies with long-term of HIV-1 non-progressors. J Neuroimmunol 2004; 147:21-5. [PMID: 14741421 DOI: 10.1016/j.jneuroim.2003.10.038] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
Recreational drug use has been proposed to affect the course of human immunodeficiency virus (HIV) infections. To investigate the effects of substance abuse on HIV infections, we compared virus-specific cytotoxic T lymphocyte (CTL) responses and the expression of IL-16, TGF-beta1, and CXCR4 in three different cohorts of HIV-infected patients: (1) long-term nonprogressors (LT-NPs) of HIV infection who do not use recreational drugs; (2) nondrugs using normal progressors (NPs), and (3) drugs using NPs. Our results show that LT-NPs manifest increased CTL activity and IL-16 expression and decreased expression of TGF-beta1 and CXCR4 compared to NPs, regardless of recreational drug usage. Furthermore, drugs using NPs showed significantly lower levels of CTL and IL-16 expression and increased TGF-beta1 and CXCR4 expression compared to nondrugs using NPs. Our results suggest that recreational drug use may reduce CTL and IL-16 expression and increase the expression of TGF-beta1 and CXCR4, all of which may facilitate progression of HIV infections.
Collapse
|
165
|
Crider A, Liu S, Li T, Mahajan S, Ankersen M, Stidsen C. Somatostatin Receptor Subtype 4 (sst4) Ligands: Synthesis and Evaluation of Indol-3-yl- and 2-Pyridyl-Thioureas. LETT DRUG DES DISCOV 2004. [DOI: 10.2174/1570180043485761] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
166
|
Adams J, Adler C, Aggarwal MM, Ahammed Z, Amonett J, Anderson BD, Anderson M, Arkhipkin D, Averichev GS, Badyal SK, Balewski J, Barannikova O, Barnby LS, Baudot J, Bekele S, Belaga VV, Bellwied R, Berger J, Bezverkhny BI, Bhardwaj S, Bhaskar P, Bhati AK, Bichsel H, Billmeier A, Bland LC, Blyth CO, Bonner BE, Botje M, Boucham A, Brandin A, Bravar A, Cadman RV, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Carroll J, Castillo J, Castro M, Cebra D, Chaloupka P, Chattopadhyay S, Chen HF, Chen Y, Chernenko SP, Cherney M, Chikanian A, Choi B, Christie W, Coffin JP, Cormier TM, Cramer JG, Crawford HJ, Das D, Das S, Derevschikov AA, Didenko L, Dietel T, Dong X, Draper JE, Du F, Dubey AK, Dunin VB, Dunlop JC, Dutta Majumdar MR, Eckardt V, Efimov LG, Emelianov V, Engelage J, Eppley G, Erazmus B, Fachini P, Faine V, Faivre J, Fatemi R, Filimonov K, Filip P, Finch E, Fisyak Y, Flierl D, Foley KJ, Fu J, Gagliardi CA, Ganti MS, Gutierrez TD, Gagunashvili N, Gans J, Gaudichet L, Germain M, Geurts F, Ghazikhanian V, Ghosh P, Gonzalez JE, Grachov O, Grigoriev V, Gronstal S, Grosnick D, Guedon M, Guertin SM, Gupta A, Gushin E, Hallman TJ, Hardtke D, Harris JW, Heinz M, Henry TW, Heppelmann S, Herston T, Hippolyte B, Hirsch A, Hjort E, Hoffmann GW, Horsley M, Huang HZ, Huang SL, Humanic TJ, Igo G, Ishihara A, Jacobs P, Jacobs WW, Janik M, Johnson I, Jones PG, Judd EG, Kabana S, Kaneta M, Kaplan M, Keane D, Kiryluk J, Kisiel A, Klay J, Klein SR, Klyachko A, Koetke DD, Kollegger T, Konstantinov AS, Kopytine M, Kotchenda L, Kovalenko AD, Kramer M, Kravtsov P, Krueger K, Kuhn C, Kulikov AI, Kumar A, Kunde GJ, Kunz CL, Kutuev RK, Kuznetsov AA, Lamont MAC, Landgraf JM, Lange S, Lansdell CP, Lasiuk B, Laue F, Lauret J, Lebedev A, Lednický R, Leontiev VM, LeVine MJ, Li C, Li Q, Lindenbaum SJ, Lisa MA, Liu F, Liu L, Liu Z, Liu QJ, Ljubicic T, Llope WJ, Long H, Longacre RS, Lopez-Noriega M, Love WA, Ludlam T, Lynn D, Ma J, Ma YG, Magestro D, Mahajan S, Mangotra LK, Mahapatra DP, Majka R, Manweiler R, Margetis S, Markert C, Martin L, Marx J, Matis HS, Matulenko YA, McShane TS, Meissner F, Melnick Y, Meschanin A, Messer M, Miller ML, Milosevich Z, Minaev NG, Mironov C, Mishra D, Mitchell J, Mohanty B, Molnar L, Moore CF, Mora-Corral MJ, Morozov V, de Moura MM, Munhoz MG, Nandi BK, Nayak SK, Nayak TK, Nelson JM, Nevski P, Nikitin VA, Nogach LV, Norman B, Nurushev SB, Odyniec G, Ogawa A, Okorokov V, Oldenburg M, Olson D, Paic G, Pandey SU, Pal SK, Panebratsev Y, Panitkin SY, Pavlinov AI, Pawlak T, Perevoztchikov V, Peryt W, Petrov VA, Phatak SC, Picha R, Planinic M, Pluta J, Porile N, Porter J, Poskanzer AM, Potekhin M, Potrebenikova E, Potukuchi BVKS, Prindle D, Pruneau C, Putschke J, Rai G, Rakness G, Raniwala R, Raniwala S, Ravel O, Ray RL, Razin SV, Reichhold D, Reid JG, Renault G, Retiere F, Ridiger A, Ritter HG, Roberts JB, Rogachevski OV, Romero JL, Rose A, Roy C, Ruan LJ, Rykov V, Sahoo R, Sakrejda I, Salur S, Sandweiss J, Savin I, Schambach J, Scharenberg RP, Schmitz N, Schroeder LS, Schweda K, Seger J, Seliverstov D, Seyboth P, Shahaliev E, Shao M, Sharma M, Shestermanov KE, Shimanskii SS, Singaraju RN, Simon F, Skoro G, Smirnov N, Snellings R, Sood G, Sorensen P, Sowinski J, Spinka HM, Srivastava B, Stanislaus S, Stock R, Stolpovsky A, Strikhanov M, Stringfellow B, Struck C, Suaide AAP, Sugarbaker E, Suire C, Sumbera M, Surrow B, Symons TJM, Szanto de Toledo A, Szarwas P, Tai A, Takahashi J, Tang AH, Thein D, Thomas JH, Tikhomirov V, Tokarev M, Tonjes MB, Trainor TA, Trentalange S, Tribble RE, Trivedi MD, Trofimov V, Tsai O, Ullrich T, Underwood DG, Van Buren G, VanderMolen AM, Vasiliev AN, Vasiliev M, Vigdor SE, Viyogi YP, Voloshin SA, Waggoner W, Wang F, Wang G, Wang XL, Wang ZM, Ward H, Watson JW, Wells R, Westfall GD, Whitten C, Wieman H, Willson R, Wissink SW, Witt R, Wood J, Wu J, Xu N, Xu Z, Xu ZZ, Yakutin AE, Yamamoto E, Yang J, Yepes P, Yurevich VI, Zanevski YV, Zborovský I, Zhang H, Zhang HY, Zhang WM, Zhang ZP, Zołnierczuk PA, Zoulkarneev R, Zoulkarneeva J, Zubarev AN. Pion-Kaon correlations in central Au+Au collisions at square root [sNN] = 130 GeV. PHYSICAL REVIEW LETTERS 2003; 91:262302. [PMID: 14754044 DOI: 10.1103/physrevlett.91.262302] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/30/2003] [Indexed: 05/24/2023]
Abstract
Pion-kaon correlation functions are constructed from central Au+Au STAR data taken at sqrt[s(NN)]=130 GeV by the STAR detector at the Relativistic Heavy Ion Collider (RHIC). The results suggest that pions and kaons are not emitted at the same average space-time point. Space-momentum correlations, i.e., transverse flow, lead to a space-time emission asymmetry of pions and kaons that is consistent with the data. This result provides new independent evidence that the system created at RHIC undergoes a collective transverse expansion.
Collapse
|
167
|
Sachdev D, Amladi S, Natraj G, Baveja S, Kharkar V, Mahajan S, Khopkar U. An outbreak of methicillin-resistant Staphylococcus aureus (MRSA) infection in dermatology indoor patients. Indian J Dermatol Venereol Leprol 2003; 69:377-80. [PMID: 17642945] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/16/2023]
Abstract
BACKGROUND Methicillin-resistant Staphylococcus aureus (MRSA) is a major nosocomial pathogen. Indiscriminate and increased use of systemic antibiotics has led to the emergence of MRSA. Infected or colonized ward patients are the main reservoir of infection. Once colonized, the risk of subsequent local and systemic infections is high, especially in the elderly, and in debilitated and immunosuppressed patients. METHODS We report an outbreak of MRSA in the dermatology ward of a tertiary care hospital and describe measures taken to control it. RESULTS Ten patients were found to be MRSA positive over a span of three months while screening swabs from wet lesions in indoor patients. On the basis of risk assessment, they were treated with appropriate systemic and topical therapy. One patient died while the remaining nine patients showed a good response to therapy. All the MRSA isolates were found to be sensitive to vancomycin, teicoplanin and linezolid. CONCLUSION This is the first case report of MRSA infection in dermatology indoor patients in India.
Collapse
|
168
|
Adams J, Adler C, Aggarwal MM, Ahammed Z, Amonett J, Anderson BD, Anderson M, Arkhipkin D, Averichev GS, Badyal SK, Balewski J, Barannikova O, Barnby LS, Baudot J, Bekele S, Belaga VV, Bellwied R, Berger J, Bezverkhny BI, Bhardwaj S, Bhaskar P, Bhati AK, Bichsel H, Billmeier A, Bland LC, Blyth CO, Bonner BE, Botje M, Boucham A, Brandin A, Bravar A, Cadman RV, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Carroll J, Castillo J, Castro M, Cebra D, Chaloupka P, Chattopadhyay S, Chen HF, Chen Y, Chernenko SP, Cherney M, Chikanian A, Choi B, Christie W, Coffin JP, Cormier TM, Cramer JG, Crawford HJ, Das D, Das S, Derevschikov AA, Didenko L, Dietel T, Dong X, Draper JE, Drees KA, Du F, Dubey AK, Dunin VB, Dunlop JC, Dutta Majumdar MR, Eckardt V, Efimov LG, Emelianov V, Engelage J, Eppley G, Erazmus B, Fachini P, Faine V, Faivre J, Fatemi R, Filimonov K, Filip P, Finch E, Fisyak Y, Flierl D, Foley KJ, Fu J, Gagliardi CA, Ganti MS, Gagunashvili N, Gans J, Gaudichet L, Germain M, Geurts F, Ghazikhanian V, Ghosh P, Gonzalez JE, Grachov O, Grigoriev V, Gronstal S, Grosnick D, Guedon M, Guertin SM, Gupta A, Gushin E, Gutierrez TD, Hallman TJ, Hardtke D, Harris JW, Heinz M, Henry TW, Heppelmann S, Herston T, Hippolyte B, Hirsch A, Hjort E, Hoffmann GW, Horsley M, Huang HZ, Huang SL, Humanic TJ, Igo G, Ishihara A, Jacobs P, Jacobs WW, Janik M, Johnson I, Jones PG, Judd EG, Kabana S, Kaneta M, Kaplan M, Keane D, Kiryluk J, Kisiel A, Klay J, Klein SR, Klyachko A, Kollegger T, Konstantinov AS, Kopytine M, Kotchenda L, Kovalenko AD, Kramer M, Kravtsov P, Krueger K, Kuhn C, Kulikov AI, Kumar A, Kunde GJ, Kunz CL, Kutuev RK, Kuznetsov AA, Lamont MAC, Landgraf JM, Lange S, Lansdell CP, Lasiuk B, Laue F, Lauret J, Lebedev A, Lednický R, Leontiev VM, LeVine MJ, Li C, Li Q, Lindenbaum SJ, Lisa MA, Liu F, Liu L, Liu Z, Liu QJ, Ljubicic T, Llope WJ, Long H, Longacre RS, Lopez-Noriega M, Love WA, Ludlam T, Lynn D, Ma J, Ma YG, Magestro D, Mahajan S, Mangotra LK, Mahapatra DP, Majka R, Manweiler R, Margetis S, Markert C, Martin L, Marx J, Matis HS, Matulenko YA, McShane TS, Meissner F, Melnick Y, Meschanin A, Messer M, Miller ML, Milosevich Z, Minaev NG, Mironov C, Mishra D, Mitchell J, Mohanty B, Molnar L, Moore CF, Mora-Corral MJ, Morozov V, de Moura MM, Munhoz MG, Nandi BK, Nayak SK, Nayak TK, Nelson JM, Nevski P, Nikitin VA, Nogach LV, Norman B, Nurushev SB, Odyniec G, Ogawa A, Okorokov V, Oldenburg M, Olson D, Paic G, Pandey SU, Pal SK, Panebratsev Y, Panitkin SY, Pavlinov AI, Pawlak T, Perevoztchikov V, Peryt W, Petrov VA, Phatak SC, Picha R, Planinic M, Pluta J, Porile N, Porter J, Poskanzer AM, Potekhin M, Potrebenikova E, Potukuchi BVKS, Prindle D, Pruneau C, Putschke J, Rai G, Rakness G, Raniwala R, Raniwala S, Ravel O, Ray RL, Razin SV, Reichhold D, Reid JG, Renault G, Retiere F, Ridiger A, Ritter HG, Roberts JB, Rogachevski OV, Romero JL, Rose A, Roy C, Ruan LJ, Rykov V, Sahoo R, Sakrejda I, Salur S, Sandweiss J, Savin I, Schambach J, Scharenberg RP, Schmitz N, Schroeder LS, Schweda K, Seger J, Seliverstov D, Seyboth P, Shahaliev E, Shao M, Sharma M, Shestermanov KE, Shimanskii SS, Singaraju RN, Simon F, Skoro G, Smirnov N, Snellings R, Sood G, Sorensen P, Sowinski J, Spinka HM, Srivastava B, Stanislaus S, Stock R, Stolpovsky A, Strikhanov M, Stringfellow B, Struck C, Suaide AAP, Sugarbaker E, Suire C, Sumbera M, Surrow B, Symons TJM, Szanto de Toledo A, Szarwas P, Tai A, Takahashi J, Tang AH, Thein D, Thomas JH, Tikhomirov V, Tokarev M, Tonjes MB, Trainor TA, Trentalange S, Tribble RE, Trivedi MD, Trofimov V, Tsai O, Ullrich T, Underwood DG, Van Buren G, VanderMolen AM, Vasiliev AN, Vasiliev M, Vigdor SE, Viyogi YP, Voloshin SA, Waggoner W, Wang F, Wang G, Wang XL, Wang ZM, Ward H, Watson JW, Wells R, Westfall GD, Whitten C, Wieman H, Willson R, Wissink SW, Witt R, Wood J, Wu J, Xu N, Xu Z, Xu ZZ, Yakutin AE, Yamamoto E, Yang J, Yepes P, Yurevich VI, Zanevski YV, Zborovský I, Zhang H, Zhang HY, Zhang WM, Zhang ZP, Zołnierczuk PA, Zoulkarneev R, Zoulkarneeva J, Zubarev AN. Transverse-momentum and collision-energy dependence of high-pT hadron suppression in Au+Au collisions at ultrarelativistic energies. PHYSICAL REVIEW LETTERS 2003; 91:172302. [PMID: 14611336 DOI: 10.1103/physrevlett.91.172302] [Citation(s) in RCA: 67] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/21/2003] [Revised: 09/03/2003] [Indexed: 05/24/2023]
Abstract
We report high statistics measurements of inclusive charged hadron production in Au+Au and p+p collisions at sqrt[s(NN)]=200 GeV. A large, approximately constant hadron suppression is observed in central Au+Au collisions for 5<p(T)<12 GeV/c. The collision energy dependence of the yields and the centrality and p(T) dependence of the suppression provide stringent constraints on theoretical models of suppression. Models incorporating initial-state gluon saturation or partonic energy loss in dense matter are largely consistent with observations. We observe no evidence of p(T)-dependent suppression, which may be expected from models incorporating jet attenuation in cold nuclear matter or scattering of fragmentation hadrons.
Collapse
|
169
|
Adams J, Adler C, Aggarwal MM, Ahammed Z, Amonett J, Anderson BD, Anderson M, Arkhipkin D, Averichev GS, Badyal SK, Balewski J, Barannikova O, Barnby LS, Baudot J, Bekele S, Belaga VV, Bellwied R, Berger J, Bezverkhny BI, Bhardwaj S, Bhaskar P, Bhati AK, Bichsel H, Billmeier A, Bland LC, Blyth CO, Bonner BE, Botje M, Boucham A, Brandin A, Bravar A, Cadman RV, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Carroll J, Castillo J, Castro M, Cebra D, Chaloupka P, Chattopadhyay S, Chen HF, Chen Y, Chernenko SP, Cherney M, Chikanian A, Choi B, Christie W, Coffin JP, Cormier TM, Cramer JG, Crawford HJ, Das D, Das S, Derevschikov AA, Didenko L, Dietel T, Dong X, Draper JE, Du F, Dubey AK, Dunin VB, Dunlop JC, Dutta Majumdar MR, Eckardt V, Efimov LG, Emelianov V, Engelage J, Eppley G, Erazmus B, Fachini P, Faine V, Faivre J, Fatemi R, Filimonov K, Filip P, Finch E, Fisyak Y, Flierl D, Foley KJ, Fu J, Gagliardi CA, Ganti MS, Gagunashvili N, Gans J, Gaudichet L, Germain M, Geurts F, Ghazikhanian V, Ghosh P, Gonzalez JE, Grachov O, Grigoriev V, Gronstal S, Grosnick D, Guedon M, Guertin SM, Gupta A, Gushin E, Gutierrez TD, Hallman TJ, Hardtke D, Harris JW, Heinz M, Henry TW, Heppelmann S, Herston T, Hippolyte B, Hirsch A, Hjort E, Hoffmann GW, Horsley M, Huang HZ, Huang SL, Humanic TJ, Igo G, Ishihara A, Jacobs P, Jacobs WW, Janik M, Johnson I, Jones PG, Judd EG, Kabana S, Kaneta M, Kaplan M, Keane D, Kiryluk J, Kisiel A, Klay J, Klein SR, Klyachko A, Koetke DD, Kollegger T, Konstantinov AS, Kopytine M, Kotchenda L, Kovalenko AD, Kramer M, Kravtsov P, Krueger K, Kuhn C, Kulikov AI, Kumar A, Kunde GJ, Kunz CL, Kutuev RK, Kuznetsov AA, Lamont MAC, Landgraf JM, Lange S, Lansdell CP, Lasiuk B, Laue F, Lauret J, Lebedev A, Lednický R, Leontiev VM, LeVine MJ, Li C, Li Q, Lindenbaum SJ, Lisa MA, Liu F, Liu L, Liu Z, Liu QJ, Ljubicic T, Llope WJ, Long H, Longacre RS, Lopez-Noriega M, Love WA, Ludlam T, Lynn D, Ma J, Ma YG, Magestro D, Mahajan S, Mangotra LK, Mahapatra DP, Majka R, Manweiler R, Margetis S, Markert C, Martin L, Marx J, Matis HS, Matulenko YA, McShane TS, Meissner F, Melnick Y, Meschanin A, Messer M, Miller ML, Milosevich Z, Minaev NG, Mironov C, Mishra D, Mitchell J, Mohanty B, Molnar L, Moore CF, Mora-Corral MJ, Morozov V, de Moura MM, Munhoz MG, Nandi BK, Nayak SK, Nayak TK, Nelson JM, Nevski P, Nikitin VA, Nogach LV, Norman B, Nurushev SB, Odyniec G, Ogawa A, Okorokov V, Oldenburg M, Olson D, Paic G, Pandey SU, Pal SK, Panebratsev Y, Panitkin SY, Pavlinov AI, Pawlak T, Perevoztchikov V, Peryt W, Petrov VA, Phatak SC, Picha R, Planinic M, Pluta J, Porile N, Porter J, Poskanzer AM, Potekhin M, Potrebenikova E, Potukuchi BVKS, Prindle D, Pruneau C, Putschke J, Rai G, Rakness G, Raniwala R, Raniwala S, Ravel O, Ray RL, Razin SV, Reichhold D, Reid JG, Renault G, Retiere F, Ridiger A, Ritter HG, Roberts JB, Rogachevski OV, Romero JL, Rose A, Roy C, Ruan LJ, Rykov V, Sahoo R, Sakrejda I, Salur S, Sandweiss J, Savin I, Schambach J, Scharenberg RP, Schmitz N, Schroeder LS, Schweda K, Seger J, Seliverstov D, Seyboth P, Shahaliev E, Shao M, Sharma M, Shestermanov KE, Shimanskii SS, Singaraju RN, Simon F, Skoro G, Smirnov N, Snellings R, Sood G, Sorensen P, Sowinski J, Spinka HM, Srivastava B, Stanislaus S, Stock R, Stolpovsky A, Strikhanov M, Stringfellow B, Struck C, Suaide AAP, Sugarbaker E, Suire C, Sumbera M, Surrow B, Symons TJM, Szanto de Toledo A, Szarwas P, Tai A, Takahashi J, Tang AH, Thein D, Thomas JH, Tikhomirov V, Tokarev M, Tonjes MB, Trainor TA, Trentalange S, Tribble RE, Trivedi MD, Trofimov V, Tsai O, Ullrich T, Underwood DG, Van Buren G, VanderMolen AM, Vasiliev AN, Vasiliev M, Vigdor SE, Viyogi YP, Voloshin SA, Waggoner W, Wang F, Wang G, Wang XL, Wang ZM, Ward H, Watson JW, Wells R, Westfall GD, Whitten C, Wieman H, Willson R, Wissink SW, Witt R, Wood J, Wu J, Xu N, Xu Z, Xu ZZ, Yakutin AE, Yamamoto E, Yang J, Yepes P, Yurevich VI, Zanevski YV, Zborovský I, Zhang H, Zhang HY, Zhang WM, Zhang ZP, Zołnierczuk PA, Zoulkarneev R, Zoulkarneeva J, Zubarev AN. Evidence from d+Au measurements for final-state suppression of high-p(T) hadrons in Au+Au collisions at RHIC. PHYSICAL REVIEW LETTERS 2003; 91:072304. [PMID: 12935009 DOI: 10.1103/physrevlett.91.072304] [Citation(s) in RCA: 35] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/18/2003] [Revised: 08/08/2003] [Indexed: 05/24/2023]
Abstract
We report measurements of single-particle inclusive spectra and two-particle azimuthal distributions of charged hadrons at high transverse momentum (high p(T)) in minimum bias and central d+Au collisions at sqrt[s(NN)]=200 GeV. The inclusive yield is enhanced in d+Au collisions relative to binary-scaled p+p collisions, while the two-particle azimuthal distributions are very similar to those observed in p+p collisions. These results demonstrate that the strong suppression of the inclusive yield and back-to-back correlations at high p(T) previously observed in central Au+Au collisions are due to final-state interactions with the dense medium generated in such collisions.
Collapse
|
170
|
Aithal D, Reddy BS, Mahajan S, Boaz K, Kamboj M. Ameloblastomatous calcifying odontogenic cyst: a rare histologic variant. J Oral Pathol Med 2003; 32:376-8. [PMID: 12787045 DOI: 10.1034/j.1600-0714.2003.00141.x] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
Calcifying odontogenic cyst (COC) is an uncommon developmental odontogenic cyst first described by Gorlin in 1962. It is considered as extremely rare and accounts for only 1% of jaw cysts reported. Because of its diverse histopathology, there has always been confusion about its nature as a cyst, neoplasm or hamartoma. Several subclassifications have been proposed. Here, we present a case of calcifying odontogenic cyst with ameloblastic proliferation - an extremely rare histologic variant. The classical histologic features of the lining epithelium in the form of cords and presence of characteristic ghost cells were seen along with ameloblastomatous proliferations. Ameloblastomatous COC microscopically resembles unicystic ameloblastoma except for the ghost cells and calcifications within the proliferative epithelium. The nature of the COC is controversial. The case is presented here for its rarity, and difference between ameloblastomatous COC and ameloblastoma ex COC has been emphasized.
Collapse
|
171
|
Mahajan S, Koranne RV, Sharma SK. Cutaneous manifestation of diabetes mellitus. Indian J Dermatol Venereol Leprol 2003; 69:105-8. [PMID: 17642848] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/16/2023]
Abstract
One hundred consecutive diabetes mellitus patients attending the diabetic clinic of the hospital constituted the study group. One hundred age and sex matched non-diabetics were taken as controls. The majority, 63%, belonged to the 41-60 years age group and 98% had non-insulin dependent diabetes. Among the study group, 64% had one or more cutaneous manifestations as compared to 22% in the controls. This was statistically highly significant (p < 0.001). Infections comprised the largest group affecting 35 of the 64 cases. Among the bacterial infections, pyodermas were observed in 11 and erythrasma in one. Fungal infections were seen in 21, dermatophytoses in 11, and candidiasis in 10. Herpes zoster was seen in 2 cases. Pruritus was observed in 10, neurological abnormalities in the form of paresthesias was seen in 6, mal perforans in one, and meralgia paresthetica in one. Diabetic dermopathy was seen in 6 and rubeosis in 4. Six dermatoses strongly associated with DM were seen, namely one each of waxy skin syndrome, granuloma annulare, eruptive xanthoma, scleredema adultorum, and 2 cases of diabetic bulla. Ten patients exhibited other dermotoses less associated with diabetics: xanthelasmo palpebrarum in 5 patients, acrochordi in 4, and pigmented purpuric dermatoses in one. Likewise syndromes of insulin resistance were seen in 4 patients of whom 3 had aconthosis nigricans and one had congenital lipodystrophy. Furthermore, 9 patients had dermatoses known to be associated with an increased incidence of diabetes; vitiligo in 4, acquired perforating dermatoses in 3, and lichen planus in 2. Four patients had dermatoses known to be associated with diabetes: psoriasis in 3 and diffuse alopecia in one. Three had adverse drug reactions to anti-diabetic therapy.
Collapse
|
172
|
Bhowmik D, Dinda AK, Khilnani GC, Mahajan S, Gupta S, Agarwal SK, Tiwari SC, Dash SC. Pulmonary mucormycosis in a diabetic renal transplant patient. THE INDIAN JOURNAL OF CHEST DISEASES & ALLIED SCIENCES 2002; 44:275-7. [PMID: 12437244] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/27/2023]
Abstract
A 50-year-old male, diabetic, post transplant patient had recurrent pneumonia. The first episode responded well to antibiotics, while on the second occasion he had a necrotising pneumonia, which developed into a thick-walled cavity. Despite antibiotics, his condition rapidly deteriorated precluding bronchoscopy or percutaneous biopsy. Post-mortem lung biopsy revealed typical hyphae of mucormycosis.
Collapse
|
173
|
Nair MP, Mahajan S, Chadha KC, Nair NM, Hewitt RG, Pillai SK, Chadha P, Sukumaran PC, Schwartz SA. Effect of cocaine on chemokine and CCR-5 gene expression by mononuclear cells from normal donors and HIV-1 infected patients. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 2002; 493:235-40. [PMID: 11727771 DOI: 10.1007/0-306-47611-8_28] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
|
174
|
Jefford CW, Mahajan S, Waslyn J, Waegell B. The Stereochemistry of the Bicyclo[3.2.1]octane System. III.1,2 The Addition of Dihalocarbene to Bicyclic Olefins. J Am Chem Soc 2002. [DOI: 10.1021/ja01088a016] [Citation(s) in RCA: 46] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
175
|
Narayanan V, Mahajan S, Bachmann KJ, Woods V, Dietz N. Stacking faults and twins in gallium phosphide layers grown on silicon. ACTA ACUST UNITED AC 2002. [DOI: 10.1080/01418610208243196] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
176
|
Sardana K, Koranne RV, Sharma RC, Mahajan S. Angiokeratoma circumscriptum naeviforme: rare presentation on the neck. Australas J Dermatol 2001; 42:294-5. [PMID: 11903167 DOI: 10.1046/j.1440-0960.2001.00540.x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
177
|
Sardana K, Koranne RV, Sharma RC, Mahajan S. Tuberculosis of the vulva masquerading as a sexually transmitted disease. J Dermatol 2001; 28:505-7. [PMID: 11603393 DOI: 10.1111/j.1346-8138.2001.tb00020.x] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
Tuberculosis of the vulva is a rare condition usually seen by a gynecologist. We report a case of chronic ulcer on the vulva of four months duration, which, on detailed investigation, turned out to be a case of primary inoculation tuberculosis. The patient was subsequently put on antitubercular therapy with a good the therapeutic response. The rarity of this presentation in dermato-venereology is emphasized.
Collapse
|
178
|
Mahajan S, Vassilev A, Sun N, Ozer Z, Mao C, Uckun FM. Transcription factor STAT5A is a substrate of Bruton's tyrosine kinase in B cells. J Biol Chem 2001; 276:31216-28. [PMID: 11413148 DOI: 10.1074/jbc.m104874200] [Citation(s) in RCA: 47] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
STAT5A is a molecular regulator of proliferation, differentiation, and apoptosis in lymphohematopoietic cells. Here we show that STAT5A can serve as a functional substrate of Bruton's tyrosine kinase (BTK). Purified recombinant BTK was capable of directly binding purified recombinant STAT5A with high affinity (K(d) = 44 nm), as determined by surface plasmon resonance using a BIAcore biosensor system. BTK was also capable of tyrosine-phosphorylating ectopically expressed recombinant STAT5A on Tyr(694) both in vitro and in vivo in a Janus kinase 3-independent fashion. BTK phosphorylated the Y665F, Y668F, and Y682F,Y683F mutants but not the Y694F mutant of STAT5A. STAT5A mutations in the Src homology 2 (SH2) and SH3 domains did not alter the BTK-mediated tyrosine phosphorylation. Recombinant BTK proteins with mutant pleckstrin homology, SH2, or SH3 domains were capable of phosphorylating STAT5A, whereas recombinant BTK proteins with SH1/kinase domain mutations were not. In pull-down experiments, only full-length BTK and its SH1/kinase domain (but not the pleckstrin homology, SH2, or SH3 domains) were capable of binding STAT5A. Ectopically expressed BTK kinase domain was capable of tyrosine-phosphorylating STAT5A both in vitro and in vivo. BTK-mediated tyrosine phosphorylation of ectopically expressed wild type (but not Tyr(694) mutant) STAT5A enhanced its DNA binding activity. In BTK-competent chicken B cells, anti-IgM-stimulated tyrosine phosphorylation of STAT5 protein was prevented by pretreatment with the BTK inhibitor LFM-A13 but not by pretreatment with the JAK3 inhibitor HI-P131. B cell antigen receptor ligation resulted in enhanced tyrosine phosphorylation of STAT5 in BTK-deficient chicken B cells reconstituted with wild type human BTK but not in BTK-deficient chicken B cells reconstituted with kinase-inactive mutant BTK. Similarly, anti-IgM stimulation resulted in enhanced tyrosine phosphorylation of STAT5A in BTK-competent B cells from wild type mice but not in BTK-deficient B cells from XID mice. In contrast to B cells from XID mice, B cells from JAK3 knockout mice showed a normal STAT5A phosphorylation response to anti-IgM stimulation. These findings provide unprecedented experimental evidence that BTK plays a nonredundant and pivotal role in B cell antigen receptor-mediated STAT5A activation in B cells.
Collapse
|
179
|
Arbiser JL, Yeung R, Weiss SW, Arbiser ZK, Amin MB, Cohen C, Frank D, Mahajan S, Herron GS, Yang J, Onda H, Zhang HB, Bai X, Uhlmann E, Loehr A, Northrup H, Au P, Davis I, Fisher DE, Gutmann DH. The generation and characterization of a cell line derived from a sporadic renal angiomyolipoma: use of telomerase to obtain stable populations of cells from benign neoplasms. THE AMERICAN JOURNAL OF PATHOLOGY 2001; 159:483-91. [PMID: 11485907 PMCID: PMC1850536 DOI: 10.1016/s0002-9440(10)61720-8] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
Angiomyolipomas are benign tumors of the kidney derived from putative perivascular epithelioid cells, that may undergo differentiation into cells with features of melanocytes, smooth muscle, and fat. To gain further insight into angiomyolipomas, we have generated the first human angiomyolipoma cell line by sequential introduction of SV40 large T antigen and human telomerase into human angiomyolipoma cells. These cells show phenotypic characteristics of angiomyolipomas, namely differentiation markers of smooth muscle (smooth muscle actin), adipose tissue (peroxisome proliferator-activator receptor gamma, PPARgamma), and melanocytes (microophthalmia, MITF), thus demonstrating that a single cell type can exhibit all of these phenotypes. These cells should serve as a valuable tool to elucidate signal transduction pathways underlying renal angiomyolipomas.
Collapse
|
180
|
Kalhan SC, Mahajan S, Burkett E, Reshef L, Hanson RW. Glyceroneogenesis and the source of glycerol for hepatic triacylglycerol synthesis in humans. J Biol Chem 2001; 276:12928-31. [PMID: 11278297 DOI: 10.1074/jbc.m006186200] [Citation(s) in RCA: 77] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Glyceroneogenesis, i.e. the synthesis of the glycerol moiety of triacylglycerol from pyruvate, has been suggested to be quantitatively important in both the liver and adipose tissue during fasting. However, the actual contribution of glyceroneogenesis to triacylglycerol synthesis has not been quantified in vivo in human studies. In the present study we have measured the contribution of glycerol and pyruvate to in vivo synthesis of hepatic triacylglycerol in nonpregnant and pregnant women after an overnight fast. Five nonpregnant women were administered [(13)C(3)]glycerol tracer as prime constant rate infusion, and the appearance of tracer in plasma glucose and triacylglycerol was quantified using gas chromatography-mass spectrometry. The contribution of pyruvate to hepatic triacylglycerol was quantified in nonpregnant and pregnant women using the deuterium labeling of body water method. The appearance of [(2)H] in hydrogens on C(1) and C(3) of triacylglycerol was measured following periodate oxidation of the glycerol isolated from hydrolyzed triacylglycerol. After a 16-h fast, approximately 6.1% of the plasma triacylglycerol pool was derived from plasma glycerol, whereas 10 to 60% was derived from pyruvate in nonpregnant women and pregnant women early in gestation. Our data suggest that glyceroneogenesis from pyruvate is quantitatively a major contributor to plasma triacylglycerol synthesis and may be important for the regulation of very low density lipoprotein triacylglycerol production. Our data also suggest that 3-glycerol phosphate is in rapid equilibrium with the triosephosphate pool, resulting in rapid labeling of the triose pool by the administered tracer glycerol. Because the rate of flux of triosephosphate to glucose during fasting far exceeds that to triacylglycerol, more glycerol ends up in glucose than in triacylglycerol. Alternatively, there may be two distinct pools of 3-glycerol phosphate in the liver, one involved in generating triosephosphate from glycerol and the other involved in glyceride-glycerol synthesis.
Collapse
|
181
|
Dumaswala UJ, Zhuo L, Mahajan S, Nair PN, Shertzer HG, Dibello P, Jacobsen DW. Glutathione protects chemokine-scavenging and antioxidative defense functions in human RBCs. Am J Physiol Cell Physiol 2001; 280:C867-73. [PMID: 11245604 DOI: 10.1152/ajpcell.2001.280.4.c867] [Citation(s) in RCA: 69] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Oxidant stress, in vivo or in vitro, is known to induce oxidative changes in human red blood cells (RBCs). Our objective was to examine the effect of augmenting RBC glutathione (GSH) synthesis on 1) degenerative protein loss and 2) RBC chemokine- and free radical-scavenging functions in the oxidatively stressed human RBCs by using banked RBCs as a model. Packed RBCs were stored up to 84 days at 1-6 degrees C in Adsol or in the experimental additive solution (Adsol fortified with glutamine, glycine, and N-acetyl-L-cysteine). Supplementing the conventional additive with GSH precursor amino acids improved RBC GSH synthesis and maintenance. The rise in RBC gamma-glutamylcysteine ligase activity was directly proportional to the GSH content and inversely proportional to extracellular homocysteine concentration, methemoglobin formation, and losses of the RBC proteins band 3, band 4.1, band 4.2, glyceraldehyde-3-phosphate dehydrogenase, and Duffy antigen (P < 0.01). Reduced loss of Duffy antigen correlated well with a decrease in chemokine RANTES (regulated upon activation, normal T-cell expressed, and secreted) concentration. We conclude that the concomitant loss of GSH and proteins in oxidatively stressed RBCs can compromise RBC scavenging function. Upregulating GSH synthesis can protect RBC scavenging (free radical and chemokine) function. These results have implications not only in a transfusion setting but also in conditions like diabetes and sickle cell anemia, in which RBCs are subjected to chronic/acute oxidant stresses.
Collapse
|
182
|
Mahajan S. Evaluation of slip patterns observed in association with deformation twins in Mo-35 at%Re alloy. ACTA ACUST UNITED AC 2001. [DOI: 10.1088/0305-4608/2/1/006] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
183
|
Mahajan S, Gollob JA, Ritz J, Frank DA. CD2 stimulation leads to the delayed and prolonged activation of STAT1 in T cells but not NK cells. Exp Hematol 2001; 29:209-20. [PMID: 11166460 DOI: 10.1016/s0301-472x(00)00652-4] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
OBJECTIVE T lymphocytes can be activated by soluble factors such as cytokines or through direct cell-cell interactions. Although cytokine receptors are known to signal through STAT family transcription factors, the mechanisms by which other cell-surface molecules, such as CD2, transduce signals is unclear. The goal of this study was to determine whether stimulation of T cells through CD2 recapitulates aspects of cytokine-induced T-cell activation by use of STAT transcription factors. MATERIALS AND METHODS T cells were treated with anti-CD2 antibodies or cells bearing the natural CD2 ligand CD58, after which signaling through STAT transcription factors was assessed. RESULTS Stimulation of CD2 on primary T lymphocytes leads to the tyrosine phosphorylation, nuclear translocation, and DNA binding of STAT1. In contrast to stimulation by cytokines, the activation of STAT1 in response to CD2 ligation is delayed and does not involve Jak kinases. Furthermore, while STAT phosphorylation induced by cytokines is generally transient, STAT1 phosphorylation following CD2 stimulation persists for a period of days. Transcription of key target genes such as IRF1 and c-fos proceeds with delayed kinetics following CD2 stimulation, suggesting that this unique pattern of STAT activation may lead to a distinct cellular response following CD2 ligation. This pathway appears to be restricted to T cells, as stimulation of CD2 on NK cells does not lead to STAT1 activation. CONCLUSION Stimulation of T cells through cell-surface molecules such as CD2 involves activation of STAT transcription factors, thus recapitulating elements of cytokine signaling.
Collapse
|
184
|
Suryanarayan MV, Shrivastava RK, Pandey D, Vaidyanathaswamy R, Mahajan S, Bhoumik D. Simple time weighted average level air-monitoring method for sulfur mustard in work places. J Chromatogr A 2001; 907:229-34. [PMID: 11217030 DOI: 10.1016/s0021-9673(00)01054-2] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
A simple air-monitoring method was developed and validated for vesicant sulfur mustard (HD) in the work place at time weighted average levels. XAD-2 adsorbent was used for the collection of HD vapours for 8 h followed by liquid desorption with carbon tetrachloride. The trace level analysis was carried out by gas chromatography-photoionization detection and was confirmed by gas chromatography-mass spectrometric detection in the selected ion mode.
Collapse
|
185
|
LaMontagne KR, Moses MA, Wiederschain D, Mahajan S, Holden J, Ghazizadeh H, Frank DA, Arbiser JL. Inhibition of MAP kinase kinase causes morphological reversion and dissociation between soft agar growth and in vivo tumorigenesis in angiosarcoma cells. THE AMERICAN JOURNAL OF PATHOLOGY 2000; 157:1937-45. [PMID: 11106566 PMCID: PMC1885752 DOI: 10.1016/s0002-9440(10)64832-8] [Citation(s) in RCA: 36] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
Activated ras causes increased activity of several signal transduction systems, including the mitogen-activated protein kinase kinase (MAPKK) pathway and the phosphoinositol-3-kinase (PI-3-K) pathway. We have previously shown that the PI-3-K pathway plays a major role in regulation of ras-mediated tumor angiogenesis in angiosarcoma cells. However, the contribution of the MAPKK pathway to tumorigenesis and angiogenesis is not fully understood. Overexpression of constitutively active forms of MAPKK has previously been shown to transform nonmalignant NIH3T3 fibroblasts, but the effect of down-regulation of MAPKK on tumorigenesis and angiogenesis in a well established tumor has not been fully explored. We introduced a dominant negative MAPKK gene into SVR murine angiosarcoma cells. Introduction of a dominant negative MAPKK causes a significant decrease in proliferation rate in vitro and morphological reversion. Cells expressing the dominant negative MAPKK have a greatly decreased ability to form colonies in soft agar compared with wild-type cells. Despite the decreased cell growth in vitro and inability to grow in soft agar, the cells were equally tumorigenic in nude mice. Our results suggest that the MAPKK pathway is required for soft agar growth of angiosarcoma cells, and separates the phenotypes of soft agar growth versus in vivo tumorigenicity. These findings have implications in the development of signal transduction modulators as potential antineoplastic agents.
Collapse
|
186
|
Mahajan S, Singh N, Prakash S. Activation energy of hydrogen in Al and the noble metals. ACTA ACUST UNITED AC 2000. [DOI: 10.1088/0305-4608/13/7/015] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
187
|
Mahajan S, Hou J, Sweet AM, Schwartz SA. The stress hormone, cortisol, synergizes with HIV-1 gp-120 to induce apoptosis of normal human peripheral blood mononuclear cells. Cell Mol Biol (Noisy-le-grand) 2000; 46:1227-38. [PMID: 11075952] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/18/2023]
Abstract
Both quantitative and qualitative defects in immune functions in patients with AIDS may result from induction of programmed cell death or apoptosis of CD4 T lymphocytes. We postulate that neurohormones may interact with gp-120 that is shed during active HIV infection and cause apoptosis of immunocompetent cells leading to immunopathogenesis of HIV infections. In this study, we investigated the synergistic effect of cortisol plus HIV gp-120 in inducing apoptosis of lymphocytes from normal subjects. Total peripheral blood mononuclear cells and isolated CD4+ T-cells were treated with cortisol or gp-120 separately and in combination and RNA and DNA were extracted. RNA was reverse transcribed and amplified with specific primers for Fas and Fas ligand and analyzed on agarose gels. DNA was analyzed by gel electrophoresis for ladder formation, the hallmark for apoptosis, and Fas antigen expression by confocal microscopy. Results demonstrate that cortisol and gp-120 induce apoptosis of lymphocytes from normal donors as demonstrated by DNA ladder formation, TUNEL staining and Fas gene expression. Concentrations of cortisol and gp-120 that did not produce apoptosis when used separately, induced significant apoptosis when used in combination. Further, gp-120 induced DNA fragmentation was significant in the CD4+ T-cell subpopulation compared to the CD47 subpopulation. This study suggests that the stress-associated neurohormone, cortisol, synergizes with HIV peptides in causing apoptosis of normal lymphocytes. The synergistic effect of cortisol and gp- 120 in inducing apoptosis of lymphocytes is consistent with a model proposing that stress-associated and circulating HIV-1 derived soluble products may cause progression of HIV infections.
Collapse
|
188
|
Abstract
Leukemias continue to cause significant mortality in adults and children, and the use of standard cytotoxic chemotherapy has reached a therapeutic plateau. Thus, there is great interest in treatments directed against inappropriately activated cell signaling pathways which stimulate the uncontrolled growth of neoplastic cells. Increasing evidence suggests that the STAT signaling cascade may be one target of these therapies. Signal transducer and activator of transcription (STAT) proteins are critical in mediating the response of hematopoietic cells to a diverse spectrum of cytokines. Constitutive STAT activation is present in many malignancies and has been especially well characterized in acute and chronic leukemias. While STAT activation is a common characteristic of leukemias, the specific pattern of activated STATs and the manner by which STAT activation occurs vary with each disease. STAT tyrosine phosphorylation can occur through inappropriate Jak activation or by direct activation of an oncoprotein such as Bcr/Abl, and STAT serine phosphorylation may play an important role in leukemias as well. Thus, the STAT signaling pathway is an attractive target for therapeutic intervention, and strategies designed to inhibit STAT activation and STAT mediated gene transcription may play an important role in the next generation of anti-leukemia therapies. Oncogene (2000).
Collapse
MESH Headings
- Acute Disease
- DNA-Binding Proteins/antagonists & inhibitors
- DNA-Binding Proteins/metabolism
- Humans
- Leukemia/metabolism
- Leukemia/pathology
- Leukemia/therapy
- Leukemia, Lymphocytic, Chronic, B-Cell/metabolism
- Leukemia, Lymphocytic, Chronic, B-Cell/pathology
- Leukemia, Lymphocytic, Chronic, B-Cell/therapy
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive/metabolism
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive/pathology
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive/therapy
- Leukemia-Lymphoma, Adult T-Cell/metabolism
- Leukemia-Lymphoma, Adult T-Cell/pathology
- Leukemia-Lymphoma, Adult T-Cell/therapy
- Milk Proteins
- STAT1 Transcription Factor
- STAT3 Transcription Factor
- STAT5 Transcription Factor
- Signal Transduction
- Trans-Activators/antagonists & inhibitors
- Trans-Activators/metabolism
Collapse
|
189
|
Wilbanks AM, Mahajan S, Frank DA, Druker BJ, Gilliland DG, Carroll M. TEL/PDGFbetaR fusion protein activates STAT1 and STAT5: a common mechanism for transformation by tyrosine kinase fusion proteins. Exp Hematol 2000; 28:584-93. [PMID: 10812249 DOI: 10.1016/s0301-472x(00)00138-7] [Citation(s) in RCA: 49] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
Abstract
OBJECTIVE TEL/PDGFbetaR is a tyrosine kinase fusion protein associated with the pathogenesis of chronic myelomonocytic leukemia. The following experiments were undertaken to understand the mechanisms whereby TEL/PDGFbetaR transforms cells. MATERIALS AND METHODS Activation of JAK and STAT proteins was studied in an interleukin 3 (IL-3)-dependent cell line, Ba/F3, transformed to IL-3 independence by TEL/PDGFbetaR. RESULTS TEL/PDGFbetaR activates STAT1 and STAT5 in transformed Ba/F3 cells through a JAK-independent pathway. Activation of STAT proteins requires the kinase activity of TEL/PDGFbetaR. JAK1, JAK2, JAK3, and TYK2 are not phosphorylated by TEL/PDGFbetaR. However, TEL/PDGFbetaR can phosphorylate STAT5 in transiently transfected COS cells, suggesting that TEL/PDGFbetaR may itself be the kinase involved in tyrosine phosphorylation of STAT proteins. In contrast, native PDGFbetaR stimulated by PDGF ligand does not activate STAT proteins to a significant degree in this hematopoietic context. STAT1 and STAT5 also are activated by TEL/ABL and TEL/JAK2 fusion proteins associated with human leukemia. CONCLUSIONS STAT activation may be a common mechanism of transformation by leukemogenic tyrosine kinase fusion proteins.
Collapse
|
190
|
Narayanan V, Mahajan S, Sukidi N, Bachmann KJ, Woods V, Dietz N. Orientation mediated self-assembled gallium phosphide islands grown on silicon. ACTA ACUST UNITED AC 2000. [DOI: 10.1080/01418610008212068] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
191
|
Nair MP, Chadha KC, Hewitt RG, Mahajan S, Sweet A, Schwartz SA. Cocaine differentially modulates chemokine production by mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY 2000; 7:96-100. [PMID: 10618285 PMCID: PMC95830 DOI: 10.1128/cdli.7.1.96-100.2000] [Citation(s) in RCA: 45] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/21/1999] [Accepted: 09/20/1999] [Indexed: 11/20/2022]
Abstract
Earlier studies have supported a significant role for cocaine in the susceptibility to and the progression of human immunodeficiency virus type 1 (HIV-1) infection. Recently, several unique HIV-1 entry coreceptors (e.g., CCR5 and CCR3) and a trio of HIV-1-specific suppressor chemokines, namely, RANTES (regulated-upon-activation T expressed and secreted), macrophage inflammatory protein 1alpha (MIP-1alpha) and MIP-1beta, were identified. Although cocaine has been linked to the immunopathogenesis of HIV-1 infection, the corresponding cellular and molecular mechanism(s) have not been well defined. We hypothesize that cocaine mediates these pathologic effects through the downregulation of HIV-1-suppressing chemokines and/or upregulating HIV-1 entry coreceptors in HIV-1-infected subjects, resulting in disease progression to AIDS. Our results show that cocaine selectively downregulates endogenous MIP-1beta secretion by normal peripheral blood mononuclear cells (PBMC), while cocaine did not affect the MIP-1beta production by PBMC from AIDS patients. Cocaine also selectively suppresses lipopolysaccharide-induced MIP-1beta production by PBMC from HIV-infected patients. Further, cocaine significantly downregulates endogenous MIP-1beta gene expression, while it upregulates HIV-1 entry coreceptor CCR5 by normal PBMC. These studies suggests a role for cocaine as a cofactor in the pathogenesis of HIV infection and support the premise that cocaine increases susceptibility to and progression of HIV-1 infection by inhibiting the synthesis of HIV-1 protective chemokines and/or upregulating the HIV-1 entry coreceptor, CCR5.
Collapse
|
192
|
Ghosh S, Zheng Y, Jun X, Mahajan S, Mao C, Sudbeck EA, Uckun FM. Specificity of alpha-cyano-beta-hydroxy-beta-methyl-n-[4-(trifluoromethoxy)phe nyl]-propenamide as an inhibitor of the epidermal growth factor receptor tyrosine kinase. Clin Cancer Res 1999; 5:4264-72. [PMID: 10632369] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/15/2023]
Abstract
The epidermal growth factor receptor (EGFR) tyrosine kinase has an essential function for the survival of human breast cancer cells. In a systematic effort to design potent and specific inhibitors of this receptor family protein tyrosine kinase (PTK) as antibreast cancer agents, we recently reported the construction of a three-dimensional homology model of the EGFR kinase domain. In this model, the catalytic site is defined by two beta-sheets that form an interface at the cleft between the NH2-terminal and COOH-terminal lobes of the kinase domain. Our modeling studies revealed a distinct, remarkably planar triangular binding pocket within the kinase domain with approximate dimensions of 15 A x 12 A x 12 A, and the thickness of the binding pocket is approximately 7 A with an estimated volume of approximately 600 A3 available for inhibitor binding. Molecular docking studies had identified alpha-cyano-beta-hydroxy-beta-methyl-N-[4-(trifluoromethoxy)phenyl]-p ropenamide (LFM-A12) as our lead inhibitor, with an estimated binding constant of 13 microM, which subsequently inhibited EGFR kinase in vitro with an IC50 value of 1.7 microM. LFM-A12 was also discovered to be a highly specific inhibitor of the EGFR. Even at very high concentrations ranging from 175-350 microM, this inhibitor did not affect the enzymatic activity of other PTKs, including the Janus kinases JAK1 and JAK3, the Src family kinase HCK, the Tec family member Bruton's tyrosine kinase, SYK kinase, and the receptor family PTK insulin receptor kinase. This observation is in contrast to the activity of a quinazoline inhibitor tested as a control, 4-(3-bromo, 4-hydroxyanilino)-6,7-dimethoxyquinazoline, which was shown to inhibit EGFR and other tyrosine kinases such as HCK, JAK3, and SYK.
Collapse
|
193
|
Shi X, Mahajan S, Pollock TM, Arunachalam VS. Evolution of substructures in deformed NiAl single crystals oriented for single slip. ACTA ACUST UNITED AC 1999. [DOI: 10.1080/01418619908210379] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
194
|
Sudbeck EA, Liu XP, Narla RK, Mahajan S, Ghosh S, Mao C, Uckun FM. Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents. Clin Cancer Res 1999; 5:1569-82. [PMID: 10389946] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/13/2023]
Abstract
A novel homology model of the kinase domain of Janus kinase (JAK) 3 was used for the structure-based design of dimethoxyquinazoline compounds with potent and specific inhibitory activity against JAK3. The active site of JAK3 in this homology model measures roughly 8 A x 11 A x 20 A, with a volume of approximately 530 A3 available for inhibitor binding. Modeling studies indicated that 4-(phenyl)-amino-6,7-dimethoxyquinazoline (parent compound WHI-258) would likely fit into the catalytic site of JAK3 and that derivatives of this compound that contain an OH group at the 4' position of the phenyl ring would more strongly bind to JAK3 because of added interactions with Asp-967, a key residue in the catalytic site of JAK3. These predictions were consistent with docking studies indicating that compounds containing a 4'-OH group, WHI-P131 [4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline], WHI-P154 [4-(3'-bromo-4'-hydroxylphenyl)-amino-6,7-dimethoxyquinazoline], and WHI-P97 [4-(3',5'-dibromo-4'-hydroxylphenyl)-amino-6,7-dimethoxyquinazolin e], were likely to bind favorably to JAK3, with estimated K(i)s ranging from 0.6 to 2.3 microM. These compounds inhibited JAK3 in immune complex kinase assays in a dose-dependent fashion. In contrast, compounds lacking the 4'-OH group, WHI-P79 [4-(3'-bromophenyl)-amino-6,7-dimethoxyquinazoline], WHI-P111 [4-(3'-bromo-4'-methylphenyl)-amino-6,7-dimethoxyquinazoline], WHI-P112 [4-(2',5'-dibromophenyl)-amino-6,7-dimethoxyquinazoline], WHI-P132 [4-(2'-hydroxylphenyl)-amino-6,7-dimethoxyquinazoline], and WHI-P258 [4-(phenyl)-amino-6,7-dimethoxyquinazoline], were predicted to bind less strongly, with estimated K(i)s ranging from 28 to 72 microM. These compounds did not show any significant JAK3 inhibition in kinase assays. Furthermore, the lead dimethoxyquinazoline compound, WHI-P131, which showed potent JAK3-inhibitory activity (IC50 of 78 microM), did not inhibit JAK1 and JAK2, the ZAP/SYK family tyrosine kinase SYK, the TEC family tyrosine kinase BTK, the SRC family tyrosine kinase LYN, or the receptor family tyrosine kinase insulin receptor kinase, even at concentrations as high as 350 microM. WHI-P131 induced apoptosis in JAK3-expressing human leukemia cell lines NALM-6 and LC1;19 but not in melanoma (M24-MET) or squamous carcinoma (SQ20B) cells. Leukemia cells were not killed by dimethoxyquinazoline compounds that were inactive against JAK3. WHI-P131 inhibited the clonogenic growth of JAK3-positive leukemia cell lines DAUDI, RAMOS, LC1;19, NALM-6, MOLT-3, and HL-60 (but not JAK3-negative BT-20 breast cancer, M24-MET melanoma, or SQ20B squamous carcinoma cell lines) in a concentration-dependent fashion. Potent and specific inhibitors of JAK3 such as WHI-P131 may provide the basis for the design of new treatment strategies against acute lymphoblastic leukemia, the most common form of childhood cancer.
Collapse
|
195
|
Yajnik UA, Widyan H, Choudhury D, Mahajan S, Mukherjee A. Topological defects in the left-right symmetric model and their relevance to cosmology. Int J Clin Exp Med 1999. [DOI: 10.1103/physrevd.59.103508] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
196
|
Mahajan S, Ghosh S, Sudbeck EA, Zheng Y, Downs S, Hupke M, Uckun FM. Rational design and synthesis of a novel anti-leukemic agent targeting Bruton's tyrosine kinase (BTK), LFM-A13 [alpha-cyano-beta-hydroxy-beta-methyl-N-(2, 5-dibromophenyl)propenamide]. J Biol Chem 1999; 274:9587-99. [PMID: 10092645 DOI: 10.1074/jbc.274.14.9587] [Citation(s) in RCA: 156] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
Abstract
In a systematic effort to design potent inhibitors of the anti-apoptotic tyrosine kinase BTK (Bruton's tyrosine kinase) as anti-leukemic agents with apoptosis-promoting and chemosensitizing properties, we have constructed a three-dimensional homology model of the BTK kinase domain. Our modeling studies revealed a distinct rectangular binding pocket near the hinge region of the BTK kinase domain with Leu460, Tyr476, Arg525, and Asp539 residues occupying the corners of the rectangle. The dimensions of this rectangle are approximately 18 x 8 x 9 x 17 A, and the thickness of the pocket is approximately 7 A. Advanced docking procedures were employed for the rational design of leflunomide metabolite (LFM) analogs with a high likelihood to bind favorably to the catalytic site within the kinase domain of BTK. The lead compound LFM-A13, for which we calculated a Ki value of 1.4 microM, inhibited human BTK in vitro with an IC50 value of 17.2 +/- 0.8 microM. Similarly, LFM-A13 inhibited recombinant BTK expressed in a baculovirus expression vector system with an IC50 value of 2.5 microM. The energetically favorable position of LFM-A13 in the binding pocket is such that its aromatic ring is close to Tyr476, and its substituent group is sandwiched between residues Arg525 and Asp539. In addition, LFM-A13 is capable of favorable hydrogen bonding interactions with BTK via Asp539 and Arg525 residues. Besides its remarkable potency in BTK kinase assays, LFM-A13 was also discovered to be a highly specific inhibitor of BTK. Even at concentrations as high as 100 micrograms/ml (approximately 278 microM), this novel inhibitor did not affect the enzymatic activity of other protein tyrosine kinases, including JAK1, JAK3, HCK, epidermal growth factor receptor kinase, and insulin receptor kinase. In accordance with the anti-apoptotic function of BTK, treatment of BTK+ B-lineage leukemic cells with LFM-A13 enhanced their sensitivity to ceramide- or vincristine-induced apoptosis. To our knowledge, LFM-A13 is the first BTK-specific tyrosine kinase inhibitor and the first anti-leukemic agent targeting BTK.
Collapse
|
197
|
Frank DA, Mahajan S, Ritz J. Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling. Nat Med 1999; 5:444-7. [PMID: 10202937 DOI: 10.1038/7445] [Citation(s) in RCA: 204] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
Abstract
Fludarabine is a nucleoside analog used in the treatment of hematologic malignancies that can induce severe and prolonged immunosuppression. Although it can be incorporated into the DNA of dividing cells, fludarabine is also a potent inhibitor of cells with a low growth fraction, thus it must have other mechanisms of action. STAT1, which is activated in response to many lymphocyte-activating cytokines including the interferons, is essential for cell-mediated immunity, as the absence of this protein is associated with prominent defects in the ability to control viral infections. Here we show that fludarabine, but not the immunosuppressant cyclosporine A, inhibits the cytokine-induced activation of STAT1 and STAT1-dependent gene transcription in normal resting or activated lymphocytes. Fludarabine caused a specific depletion of STAT1 protein (and mRNA) but not of other STATs. This loss of STAT1 was also seen in cells from patients treated with fludarabine in vivo. Brief exposure to fludarabine led to a sustained loss of STAT1, analogous to the prolonged period of immunosuppression induced by exposure to the drug in vivo. Thus, STAT1 may be a useful target in the development of new immunosuppressive and antineoplastic agents.
Collapse
|
198
|
Manoj N, Srinivas VR, Surolia A, Vijayan M, Suguna K, Ravishankar R, Suguna K, Surolia A, Vijayan M, Schwarzenbacher R, Zeth K, Diederichs, Kostner GM, Gries A, Laggner P, Prassl R, Madhusudan, Akamine P, Xuong NH, Taylor SS, Sagar MB, Ravishankar R, Saikrishnan K, Roy S, Purnapatre K, Handa P, Varshney U, Vijayan M, Biswal BK, Sukumar N, Vijayan M, Rao JKM, Johnson A, Pattabhi V, Krishna SS, Sastri M, Savithri HS, Murthy MRN, Pillai B, Kannan, Hosur MV, Kumar M, Patwardhan S, Kannan KK, Hosur MV, Padmanabhaa B, Sasaki-Sugio S, Nukaga M, Matsuzaki T, Karthikevan S, Sharma S, Sharma AK, Paramasivam M, Kumar P, Khan JA, Yadav S, Srinivasan A, Singh TP, Gourinath S, Alam N, Srintvasan A, Singh TP, Chandra V, Kaur P, Betzel C, Singh TP, Ghosh S, Bera AK, Bhattacharya S, Chakraborty S, Pal AK, Mukhopadhyay BP, Dey I, Haldar U, Baneriee A, Sevcik J, Solovicova A, Sekar K, Sundaralingam M, Betzel C, Genov N, Singh TP, Liang DC, Jiang T, Zhang JP, Chang WR, Jahnke W, Blommers M, Panchal SC, Hosur RV, Pillay B, Hosur MV, Mathur P, Srivatsun S, Joshi RM, Jaganathan NR, Chauhan VS, Atreya HS, Sahu SC, Chary KVR, Ponce-Homos JE, Parisi M, Capurro C, Toriano R, Ready LG, Jones LR, Thomas DD, Tashmukhamedov BA, Sagdullaev BT, Usmanov PB, Govil G, Mauricio AC, Heitzmann D, Warth R, Bleich M, Greger R, Ferreira KTG, Ferreira HG, Zagoory O, Alfahel E, Parola AH, Adjadj E, Priel Z, Hama-Inaba H, Wang R, Choi K, Nakajima T, Haginoya K, Mori M, Ohyama H, Yukawa O, Hayata I, Quinjou É, Joshi NB, Kannurpatti SK, Joshi PG, Sinha M, Shen X, Hu T, Bei L, Knetsch MLW, Schäfers N, Manstein DJ, Izadi-Pruneyre N, Sandblom J, Galvanovskis J, Pologea-Moraru R, Kovacs E, Savopol T, Dinu A, Sanghvi SH, Mishra KP, Jazbinšek V, Thiel G, Blouquit Y, Müller W, Wübeller G, Tronteli Z, Fajmut L, Marhl M, Brumen M, Volotovski ID, Sokolovski SG, Knight MR, Vasil’ev AN, Mispelter J, Chalyi AV, Sharma P, Steinbach PJ, Sharma M, Amin ND, Barchir J, Albers RW, Pant HC, Balasubramanyam M, Condrescu M, Heyd B, Reeves JP, Gardner JP, Monajembashi S, Pilarczyk G, Greulich KO, Kovacs E, El-Refaei FM, Talaat MM, El-Awadi AI, Ali FM, Lerat G, Tahradník I, Pavelková J, Zahradniková A, Zhorov BS, Ananthanaravanan VS, Michailov MC, Neu E, Seidenbusch W, Gornik E, Martin D, Milnard P, Welscher U, Weiss DG, Pattnaik BR, Jellali A, Forster V, Hicks D, Sahel J, Dreyfus H, Picaud S, Wang HW, Desmadreil M, Sui SF, Luther PK, Barry J, Morris E, Squire J, Sundari CS, Balasubramanian D, Veluraia K, Christlet THT, Suresh MX, Lin Y, Berry H, Pelta J, Lairez D, Laretta-Garde V, Krilov D, Stojanović N, Herak JN, Jasuja R, Ivanova M, Mirchev R, Rao BDN, Ferrone FA, Stopar D, Spruijt RB, Wolfs CJAM, Hemminga MA, Arcovito G, De Spirito M, Sui SF, Wang HW, Agrawal RK, Raghunathan V, Heagle AB, Penczek P, Grassucci R, Frank J, Sharma MR, Jeyakumar LH, Fleischer S, Wagenknecht T, Knupp C, Munro PMG, Chau MH, Luther PK, Ezra E, Squire JM, Ichihara K, Kitazawa H, Iguchi Y, Hotani H, Itoh TJ, Pifat G, Kveder M, Rao BDN, Pečar S, Schara M, Nair D, Singh K, Rao KVS, Salunke DM, Kaur K, Jain D, Sundaravadivel B, Goel M, Pesais P, Salunke DM, Kovalenko EI, Semenkova GN, Cherenkevich SN, Lakshmanan T, Sriram D, Srinivasan S, Loganathan D, Ramalingam TS, Lebrón JA, Srivastava S, Bjorkman PJ, Singh AK, Gayatri TN, Jain D, Kaur K, Sundaravadivel B, Salunke DM, Caffarena ER, Grigera JR, Bisch PM, Coutinho E, Kiessling V, Fromherz P, Rao KN, Gaikwad SM, Khan MI, Suresh CG, Kaliannan P, Gromiha MM, Elanthiraiyan M, Chadha K, Saran A, Payne J, Ambrus JL, Nair MPN, Nair MPN, Mahajan S, Chadha KC, Hewitt R, Schwartz SA, Bourguignon J, Faure M, Sapico LF, Cohen-Addad C, Neuburger M, Ober R, Sieker L, Macherel D, Douce R, Gurumurthy DS, Velmurugan S, Lobo Z, Srivastava S, Gesme J, Phadke RS, Govil G, Desai P, Coutinho E, Guseinova IM, Suleimanov SY, Zulfugarov IS, Novruzova SN, Aliev JA, Ismayilov MA, Lijima H, Savchenko TV, Alieva DR, Ilík P, Kouřil R, Bartošková H, Nauš J, Gaikwad JU, Thomas S, Vidyasagar PB, Garab G, Paxton R, Simidjiev I, Rajagopal S, Várkonyi Z, Stoylova S, Cseh Z, Papp E, Mustárdy L, Holzenburg A, Bruder R, Genick UK, Srikrishnan T, Woo TT, Millar DP, Gerwert K, Getzoff ED, Jávorfí T, Garab G, Naqvi KR, Kalimullah M, Gaikwad J, Thomas S, Grace CR, Semwal M, Vidyasagar PB, Kouril R, Ilik P, Naus M, Pomozi I, Horváth G, Wehner R, Bernard GD, Damjanović A, Nagenagowda G, Ritz T, Schulten K, Jushuo W, Jixiu S, Yandao G, Tingyun K, Nanming Z, Freiberg A, Timpmann K, Ruus R, Lynn AM, Woodbury NW, Nemtseva EV, Kudryasheva NS, Sizykh AG, Shikhov VN, Nesterenko TV, Tikhomirov AA, Forti G, Finazzi G, Furia A, Cowsik SM, Barbagallo RP, Forti G, Iskenderova S, Agalarov R, Gasanov R, Osamu M, Nobuhiro GO, Soni RK, Ramrakhiani M, Yagi H, Sahu SC, Tozawa K, Sekino N, Iwabuchi T, Yoshida M, Akutsu H, Avetisyan AV, Kaulen AD, Skulachev VP, Feniouk BA, Breyton C, Chauhan S, Kühlbrandt W, Assarsson M, Gräslund A, Zsiros O, Horváth G, Mustárdy L, Libisch B, Gombos Z, Budagovskaya NV, Kudryasheva N, Bhattacharya A, Harada E, Fukuoka Y, Ohmura T, Fukunishi A, Kawai G, Watanabe K, Akutsu H, Derganc J, Božič B, Svetina S, Chary KVR, Žekš B, Hoh JFY, Li ZB, Rossmanith GH, de Beer EL, Treijtel BW, Frederix PLTM, Blangè T, Hénon S, Galtet F, Govil G, Laurent V, Planus E, Isabey D, Rath LS, Dash PK, Raval MK, Ramakrishnan C, Balaram R, Randic M, Basak SC, Kumar A, Vracko M, Nandy A, Amic D, Beslo D, Nikolic S, Trinajstic N, Walahaw J, Woolfson DN, Lensink MFJ, Berendsen HJC, Pellecchia M, Reddy BVB, Shindylov IN, Bourne PE, Donnamaria MC, de Xammar Oro J, Grigera JR, Neagu M, Neagu A, Praprotnik M, Janežič D, Zuiderweg ERP, Mark P, Nilsson L, Martorana V, Bulone D, Fata LL, Manno M, Biagio PLS, Dardenne LE, Werneck AS, Neto MDO, Kawano K, Bisch PM, Kannan N, Vishveshwara S, Christlet THT, Veluraja K, Grunwald GD, Balaban AT, Basak K, Gute BD, Mills D, Aizawa T, Opitz D, Balasubramanian K, Mihalas GI, Lungeanu D, Macovievici G, Gruia R, Neagu M, Cortez-Maghelly C, Dalcin B, Passos EP, Fujitani N, Blesic S, Ljubisavljevic M, Milosevic S, Stratimirovic DJ, Bachhawat N, Mande SC, Ghosh S, Nandy A, Saito A, Nishigaki K, Hayakawa Y, Nishigaki K, Naimuddin M, Mitaku S, Hirokawa T, Ono M, Takaesu H, El Gohary MI, Ahmed AS, Eissa AM, Nakashima H, Ohnishi A, Nishikawa K, Neagu M, Neagu A, Raghava GPS, Kurgalvuk N, Goryn O, Gerstman BS, Gritsenko EV, Remmel NN, Maznyak OM, Ohkubo T, Kratasyuk VA, Esimbekova EN, Kratasyuk VA, Tchitchkan D, Koulchitsky S, Tikhonov A, German A, Pesotskaya Y, Pashkevich S, Pletnev S, Kumaki Y, Kulchitsky V, Duvvuri U, Charagundla S, Rizi R, Leigh JS, Reddy R, Kumar M, Coshic O, Julka PK, Rath OK, Hikichi K, Jagannathan NR, Iliescu KR, Sajin M, Moisoi N, Petcu I, Kuzmenko AI, Morozova RP, Nikolenko IA, Donchenko GV, Rahman MK, Nitta K, Ahmed MM, Naimuddin M, Watanabe T, Nishigaki K, Rubin Y, Gilboa H, Sharony R, Ammar R, Uretzky G, Khubchandani M, Rani Parvathy V, Mallick HN, Kumar VM, Jagannathan NR, Borthakur A, Shapiro EM, Begum MG, Degaonkar MN, Govindasamy S, Dimitrov I, Kumosani TA, Chary KVR, Bild W, Stefanescu I, Titescu G, Iliescu R, Lupusoru C, Nastasa V, Haulica I, Khetawat G, Faraday N, Nealen M, Kini RM, Noga S, Bray PF, Ananieva TV, Lycholat EA, Pashinskaya VA, Kosevich MV, Stepanyan SG, Lycholat EA, Ananieva TV, Antonyuk SV, Govil G, Khachatryan R, Arakelian H, Kumar A, Ayrapetyan S, Mkheyan V, Agadjanyan S, Khachatryan A, Rajan SS, Kabaleeswaran V, Malathi R, Koshiba T, Gopalakrishnan G, Govindachari TR, Ramrakhiani M, Lowe P, Badley A, Cullen DC, Hermel H, Schmahl W, Möhwald H, Singh AK, Kobashigawa Y, Majumdar N, Das J, Madhusudnan KS, Dér A, Kelemen L, Oroszi L, Hámori A, Ramsden JJ, Ormos P, Savitri D, Yao M, Mitra CK, Yanagida T, Esaki S, Kimura Y, Nishida T, Sowa Y, Radu M, Koltover VK, Estrin YI, Kasumova LA, Demura M, Bubnov VP, Laukhina EE, Dotta R, Degaonkar M, Raghunathan P, Jayasundar R, Jagannathan NR, Novák P, Marko M, Zahradník I, Nakagawa A, Hirata H, Miyata H, Ohki K, Balaji J, Sengupta P, Maiti S, Gonsalves M, Barker AL, Macpherson JV, O’Hare D, Tanaka I, Winlove CP, Unwin PR, Sengupta P, Phillip R, Banerjee S, Kumar GR, Maiti S, Nagayaka K, Danev R, Sugitani S, Kuwajima K, Murata K, Gősch M, Blom H, Thyberg P, Földes-Papp Z, Björk G, Holm J, Heino T, Rigler R, Yokochi M, Nitta K, Inagaki F, Kusunoki M, Matthews EK, Pines J, Chukova YP, Koltover VK, Bansal G, Singh U, Bansal MP, Nakata K, Linge J, Nakano T, Kaminuma T, Kang BPS, Singh U, Kirn B, Potocnik N, Stare V, Shukla L, Natarajan V, Devasagayam TPA, Donoghue SO, Sastry MD, Kesavan PC, Sayfutdinov R, Adamovich VV, Rogozin DY, Degermendzhy AG, Khetrapal CL, Ramanathan KV, Gowda GAN, Ghimire KN, Nilges M, Masaru I, Fujita H, Ishiwata S, Kishimoto Y, Kawahara S, Suzuki M, Mori H, Mishina M, Kirino Y, Ohshima H, Chakshusmathi G, Dukhin AS, Shilov VN, Goetz PJ, Sengupta B, Guharay J, Sengupta PK, Mishra RK, Ratnaparkhi GS, Madhu PK, Varadarajan R, Tetreau C, Tourbez M, Lavalette D, Manno M, Biagio PLS, Martorana V, Emanuele A, Vaiana SM, Bulone D, Palma-Vittorelli MB, Palma MU, Trivedi VD, Cheng SF, Chien WJ, Yang SH, Francis S, Chang DK, Batra R, Geeves MA, Manstein DJ, Trvlska J, Grochowski P, Geller M, Ginalski K, Grochowski P, Lesyng B, Lavalette P, Tetreau C, Tourbez M, Blouquit Y, Roccatano D, Amadei A, Nola AD, Berendsen HJC, Ho B, Curmi PMG, Berry H, Lairez D, Pauthe E, Pelta J, Kothekar V, Sahi S, Srinivasan M, Singh AK, Madhusudnan KS, Nandel FS, Kaur H, Nandel FS, Singh B, Jain DVS, Feenstra KA, Berendsen HJC, Tama F, Sanejouand YH, Go N, Sharma D, Sharma S, Pasha S, Brahmachari SK, Viiavaraghavan R, Makker J, Dey S, Kumar S, Singh TP, Lakshmikanth GS, Krishnamoorthy G, Mazhul VM, Zaitseva EM, Kierdaszuk B, Widengren J, Terry B, Mets Ü, Rigler R, Swaminathan R, Thamotharan S, Yathindra N, Shibata Y, Chosrowjan H, Mataga N, Morisima I, Chakraharty T, Xiao M, Cooke R, Selvin P, Branca C, Faraone A, Magazù S, Maisano G, Migliardo P, Villari V, Behere DV, Deva MSZW, Brunori M, Cutruzzolà F, Gibson QH, Savino C, Travaglini-Allocatelli C, Vallone B, Prasad S, Mazumdar S, Mitra S, Soto P, Fayad R, Sukovataya IE, Tyulkova NA, Mamedov SV, Aktas B, Canturk M, Aksakal B, Yilgin R, Bogutska KI, Miroshnichenko NS, Chacko S, DiSanto M, Hypolite JA, Zheng YM, Wein AJ, Wojciechowski M, Grycuk T, Antosiewicz J, Lesyng B, Ceruso MA, Di Nola A, Bandvopadhvay S, Chatterjee BP, Choudhury D, Thompson A, Stojanoff V, Pinkner J, Hultgren S, Khight S, Flatters D, Goodfellow J, Takazawatt F, Kanehisa M, Sasai M, Nakamura H, Sasai M, Han WB, Zheng Y, Xin WZ, Min PX, Bhakuni V, Kulkarni S, Ahmad A, Prakash K, Prajapati S, Surin A, Matsumoto T, Yang L, Nakagawa Y, Kimura K, Amemiya Y, Semisotnov GV, Kihara H, Tayyab S, Muzammil S, Kumar Y, Kulkarni S, Prajapati S, Prakash K, Ahmad A, Bhakuni V, Sundd M, Kundu S, Jagannadham MV, Kundu S, Sundd M, Jagannadham MV, Chandani B, Dhar R, Sinha L, Warrier D, Mehrotra S, Khandelwal P, Seth S, Hosur RV, Sasidhar YU, Prabha CR, Gidwani A, Ahmad A, Kulkarni S, Madhusudan KP, Bhakuni V, Kinjo AR, Nishikawa K, Chakravarty S, Varadarajan R, Noyelle K, Haezebrouck P, Joniau M, Van Dael H, Dash S, Jha IB, Bhat R, Mohanty P, Bandyopadhyay AK, Sonawat HM, Rao CM, Datta S, Rajaraman K, Raman B, Ramakrishna T, Rao CM, Pande A, Pande J, Betts S, Asherie N, Ogun O, King J, Benedek G, Sokolova IV, Tyulkova NA, Kalacheva GS, Sonoyama M, Yokoyama Y, Taira K, Mitaku S, Nakazawal C, Sasakil T, Mukai Y, Kamo N, Sonoyama M, Mitaku S, Dalal S, Regan L, Mukai Y, Kamo N, Mituku S, Roychoudhury M, Kumar D, Lőrinczv D, Könczöl F, Farkas L, Belagyi J, Schick C, Thomson CA, Ananthanarayanan VS, Alirzayeva EG, Baba-Zade SN, Gromiha MM, Oobatake M, Kono H, An J, Uedaira H, Sarai A, Takano K, Yamagata Y, Yutani K, Jas GS, Muñoz V, Hofrichter J, Eaton WA, Penoyar J, Srikrishnan T, Lo Verde PT, Kardos J, Bódi Á, Venekei I, Závodszky P, Gráf L, Szilágyi A, Závodszky P, Allan RD, Walshaw J, Woolfson DN, Funahashi J, Takano K, Yamagata Y, Yutani K, Gupta S, Mazumdar S, Di Nola A, Mangoni M, Roccatano P, Ramachandraiah G, Chandra NR, Kothekar V, Srinivasan M, Sahi S, Chakraborty S, Bhattacharya S, Bera AK, Ghosh S, Pal AK, Haldar U, Mukhopadhyay BP, Baneriee A, Ciani B, Woolfson DN, Nair UB, Kaur KJ, Salunke DM, Swaminathan CP, Surolia A, Rigler R, Pramanik A, Jonasson P, Kratz G, Jansson OT, Nygren PÅ, Ståhl S, Ekberg K, Johansson BL, Uhlén S, Uhlén M, Jörnvall H, Wahren J, Welfle K, Misselwitz R, Höhne W, Welfle H, Mazhul VM, Zaitseva EM, Mitskevich LG, Fedurkina NV, Kurganov BI, Jarori GK, Maity H, Guharay J, Sengupta B, Sengupta PK, Sridevi K, Kasturi SR, Gupta SP, Agarwal G, Kwong S, Briehl RW, Ismailova OI, Tyulkova NA, Hariharan C, Pines D, Pines E, Zamai M, Cohen-Luria R, Yayon A, Parola AH, Padya MJ, Spooner GA, Woolfeon DN, Bakshi P, Sharma D, Sharma S, Bharadwaj DK, Pasha S, Sharma U, Srivastava N, Barthwal R, Jagannathan NR, Matsuda K, Nishioka T, Go N, Aita T, Urata S, Husimi Y, Majumder M, Chatterjee BP, Abrescia NGA, Malinina L, Subirana JA, Aymami J, Eritxa R, Coll M, Premraj BJ, Yathindra N, Thenmalarchelvi R, Yathindra N, Kumar PS, Gautham N, Kan LS, Ming-Hou, Lin SB, Sana T, Roy KB, Bruant N, Flatters D, Lavery R, Genest D, Rons R, Sklenar H, Lavery R, Kundu S, Bhattacharyya D, Bandyopadhyay D, Thakur AR, Majumdar R, Barceló F, Portugal J, Ramanathan S, Chary KVR, Rao BJ, Gliosli M, Kumar NV, Varshney U, Chary KVR, Pataskar SS, Brahmachari SK, Sarojini R, Selvasekarapandian S, Kolandaivel P, Sukumar S, Selvasekarapandian S, Sarojini R, Kolmdaivel P, Sukumar S, Sarojini R, Selvasekarapandian S, Kolandaivel P, Sukumar S, Selvasekarapandian S, Sarojini R, Kolandaivel P, Sukumar S, Maiti M, Sen A, Das S, Terra ED, Suraci C, Diviacco S, Quadrifoglio F, Xodo L, Bandyopadhyay D, Bhattacharyya D, Kundu S, Thakur AR, Das S, Ray A, Maiti M, Karthikeyan G, Chary KVR, Rao BJ, Mujeeb A, James TL, Kasyanenko N, Haya EEF, Bogdanov A, Zanina A, Bugs MR, Cornélio ML, Srikrishnan T, Tolstorukov MY, Sanval NK, Tiwari SN, Tiwari SN, Sanyal NK, Choudhury MR, Kumar D, Sanyal NK, Patel PK, Bhavesh NS, Hosur RV, Gabrielian A, Wennmalm S, Edman L, Rigler R, Constantinescu B, Radu L, Radulcscu I, Gazdaru D, Wärmländer S, Leijon M, Aoki S, Kondo T, Ishiura M, Pashinskaya VA, Kosevich MV, Shelkovsky VS, Blagoy YP, Wang JH, Malathi R, Chandrasekhar K, Premraj BJ, Patel PK, Kandimalla ER, Agrawal S, Hosur RV, Yathindra N, Rastogi VK, Palafox MA, Singh C, Beniaminov AD, Bondarenko SA, Zdobnov EM, Minyat EE, Ulyanov NB, Ivanov VI, Singh JS, Sonawane KD, Grosjean H, Tewari R, Sonavane UB, Morin A, Grosjean H, Tewari R, Doherty EA, Doudna JA, Tochio H, Sato S, Matsuo H, Shirakawa M, Kyogoku Y, Javaram B, Dixit SB, Shukla P, Kalra P, Das A, McConnell K, Beveridge DL, Sawyer WH, Chan RYS, Eccelston JF, Yan Y, Davidson BE, Ray A, Tuite E, Norden B, Nielsen P, Takahashi M, Ghosh A, Bansal M, Christ F, Thole H, Wende W, Pingoud A, Pingoud V, Luthra PM, Chandra R, Sen R, King R, Weisberg R, Larsen OFA, Berends J, Heus HA, Hilbers CW, van Stokkum IHM, Gobets B, van Grondelle R, van Amerongen H, Sngrvan HE, Babayan YS, Khudaverdian NV, Kono H, Gromiha M, Pichierri F, Aida M, Prabakaran P, Sayano K, An J, Uedaira H, Sarai A, Serva S, Merkienė E, Vilkaitis G, Weinhold E, Klimašauskas S, Marsich E, Bandiera A, Xodo L, Manzini G, Potikyan G, Arakelyan V, Babayan Y, Ninaber A, Goodfellow JM, Ito Y, Ohta S, Husimi Y, Usukura J, Tagami H, Aiba H, Suarez M, Nunes E, Keszenman D, Candreva EC, Nunes E, Thyberg P, Földes-Papp Z, Rigler R, Joshi A, Rao BJ, Singh D, Rajeswari MR, Ira, Krishnamoorthy G, Pregetter M, Prassl R, Schwarzenbacher R, Amenitsch H, Chapman J, Laggner P, Pandev BN, Mishra KP, Pohl EE, Sun J, Agapov II, Tonevitsky AG, Pohl P, Dennison SM, Guharay J, Sengupta PK, Gorbeako GP, Dynbko TS, Pappavee N, Mishra AK, Manuel P, Rodrigo A, Luis L, Gendel LY, Przestalski S, Kuczera J, Kleszczyńska H, Kral T, Chernitsky EA, Senkovich OA, Rosin VV, Allakhverdieva YM, Papageorgiou GC, Gasanov RA, Apetrei C, Savopol T, Balea M, Cucu D, Mihailescu D, Ramanathan KV, Bačić G, Sajot N, Garnier N, Crouzy S, Genest M, Várkonyi ZS, Zsiros O, Farkas T, Combos Z, Cribier S, Fraceto IF, Schreier S, Spisni A, de Paula F, Sevšek F, Gomišček G, Arrigler V, Svetina S, Žekš B, Nomura F, Nagata M, Takiguchi K, Hotani H, Panicker L, Parvathanathan PS, Ishino A, Saitoh A, Hotani H, Takiguchi K, Afonin S, Takahashi A, Nakato Y, Takizawa T, Marathe D, Mishra KP, Jørgensen K, Rawat SS, Nair UB, Rukmini R, Chattopadhyay A, Šentiurc M, Štrancar J, Stolič Z, Filipin K, Pečar S, Chattopadhyay A, Biswas SC, Rukmini R, Sana S, Samanta A, Kinoshita K, Yamazaki M, Ohba T, Kiuchi T, Yoshitoshi, Kamakura, Goto A, Kumeta T, Ohki K, Sugar IP, Thompson TE, Thompson KK, Biltonen RL, Suezaki Y, Ichinose H, Takiguchi K, Hotani H, Akivama M, Matuoka S, Tsuchihashi K, Gasa S, Mattjus P, Molotkovsky JG, Pike HM, Brown RE, Arora A, Kleinschmidt JH, Tamm LK, Luneva OG, Gendel LY, Kruglyakova KE, Fedin VA, Kuptsoya OS, Borst JW, Visser NV, Visser AJWG, Dyubko TS, Ogihara T, Mishima K, Shvaleva AL, Radenović NČ, Minić PM, Jeremić MG, Radenović ČN, Aripov TF, Tadjibaeva ET, Vagina ON, Zamaraeva MV, Salakhutdinov BA, Cole A, Poppofl M, Naylor C, Titball R, Basak AK, Eaton JT, Naylor CE, Justin N, Moss DS, Titball RW, Basak AK, Nomura F, Nagata M, Ishjkawa S, Takiguchi K, Takahashi S, Hotani H, Obuchi K, Staudegger E, Kriechbaum M, Lehrer RI, Waring AJ, Lohner K, Gangl S, Mayer B, Köhler G, Shobini J, Mishra AK, Guttenberg Z, Lortz B, Hu B, Sackmann E, Kozlova NM, Lukyanenko LM, Antonovich AN, Slobozhanina EI, Chernitsky EA, Krylov AV, Antonenko YN, Kotova EA, Yaroslavov AA, Ghosh S, Bera AK, Das S, Urbánková E, Jelokhani-Niaraki M, Freeman K, Jezek P, Usmanov PB, Ongarbaev A, Tonkikh AK, Pohl P, Saparov SM, Harikumar P, Reeves JP, Rao S, Sikdar SK, Ghatpande AS, Rao S, Sikdar SK, Corsso C, Campos de Carvalho AC, Varanda WA, ElHamel C, Dé E, Saint N, Molle G, Varshney A, Mathew MK, Loots E, Isacoff EY, Kasai M, Yamaguchi N, Ghosh P, Ghosh S, Tigyi J, Tigyi G, Liliom K, Miledi R, Djurisic MR, Andjus PR, Shrivastava IH, Sansom MSP, Barrias C, Oliveira PF, Mauricio AC, Rebelo da Costa AM, Lopes IA, Barrias C, Fedorovich SV, Chubanov VS, Sholukh MV, Konev SV, Fedirko N, Manko V, Klevets M, Shvinka N, Prabhananda BS, Kombrabail MH, Aravamudhan S, Venegas-Cotero B, Blake IO, Zhang ZH, Hu XJ, Zhou HQ, Cheng WY, Feng HF, Dubitsky LO, Vovkanvch LS, Zalyvsky IA, Savio-Galimberti E, Bonazzola P. Contributory presentations/posters. J Biosci 1999. [DOI: 10.1007/bf02989373] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
199
|
Vassilev A, Ozer Z, Navara C, Mahajan S, Uckun FM. Bruton's tyrosine kinase as an inhibitor of the Fas/CD95 death-inducing signaling complex. J Biol Chem 1999; 274:1646-56. [PMID: 9880544 DOI: 10.1074/jbc.274.3.1646] [Citation(s) in RCA: 91] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Bruton's tyrosine kinase (BTK) is a member of the Src-related Tec family of protein tyrosine kinases. Mutations in the btk gene have been linked to severe developmental blocks in human B-cell ontogeny leading to X-linked agammaglobulinemia. Here, we provide unique biochemical and genetic evidence that BTK is an inhibitor of the Fas/APO-1 death-inducing signaling complex in B-lineage lymphoid cells. The Src homology 2, pleckstrin homology (PH), and kinase domains of BTK are all individually important and apparently indispensable, but not sufficient, for its function as a negative regulator of Fas-mediated apoptosis. BTK associates with Fas via its kinase and PH domains and prevents the FAS-FADD interaction, which is essential for the recruitment and activation of FLICE by Fas during the apoptotic signal. Fas-resistant DT-40 lymphoma B-cells rendered BTK-deficient through targeted disruption of the btk gene by homologous recombination knockout underwent apoptosis after Fas ligation, but wild-type DT-40 cells or BTK-deficient DT-40 cells reconstituted with wild-type human btk gene did not. Introduction of an Src homology 2 domain, a PH domain, or a kinase domain mutant human btk gene into BTK-deficient cells did not restore the resistance to Fas-mediated apoptosis. Introduction of wild-type BTK protein by electroporation rendered BTK-deficient DT-40 cells resistant to the apoptotic effects of Fas ligation. BTK-deficient RAMOS-1 human Burkitt's leukemia cells underwent apoptosis after Fas ligation, whereas BTK-positive NALM-6-UM1 human B-cell precursor leukemia cells expressing similar levels of Fas did not. Treatment of the anti-Fas-resistant NALM-6-UM1 cells with the leflunomide metabolite analog alpha-cyano-beta-methyl-beta-hydroxy-N-(2, 5-dibromophenyl)propenamide, a potent inhibitor of BTK, abrogated the BTK-Fas association without affecting the expression levels of BTK or Fas and rendered them sensitive to Fas-mediated apoptosis. The ability of BTK to inhibit the pro-apoptotic effects of Fas ligation prompts the hypothesis that apoptosis of developing B-cell precursors during normal B-cell ontogeny may be reciprocally regulated by Fas and BTK.
Collapse
|
200
|
Arora U, Mohan U, Mahajan S. Bacteriology of bronchial secretions in non-tubercular lower respiratory tract infections. THE INDIAN JOURNAL OF CHEST DISEASES & ALLIED SCIENCES 1999; 41:65-7. [PMID: 10639768] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/15/2023]
Abstract
Fifty samples of bronchial secretions collected from patients of non-tubercular lower respiratory tract infections through fiberoptic bronchoscopy (FOB) were cultured both for aerobic and anaerobic organisms. Thirty-three (66%) samples yielded bacteria. Out of these, thirty were isolated in pure culture and from three, a mixed growth of aerobic and anaerobic micro-organisms was obtained. Aerobic bacteria were the predominant isolates. Stephylococcus aureus (10), pseudomonas (9) and streptococcus pneumoniae (8) were the major aerobic isolates. Ciprofloxacin was found to be the most effective drug against aerobes and metronidazole against anaerobes in vitro susceptibility tests.
Collapse
|